All-cause Heart Failure

I9_HEARTFAIL_ALLCAUSE

congestive heart failure: Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions not I9_HYPERTROCARDMYOP	518774
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_HEARTFAIL	38165
6. Filter based on genotype QC (FinnGen only)	38165

Control definitions (FinnGen only)

Control exclude: I9_NONISCHCARDMYOP
Control conditions: not I9_HYPERTROCARDMYOP

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	I9_HEARTFAIL_ALLCAUSE
CONTROL_EXCLUDE	I9_NONISCHCARDMYOP
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!I9_HYPERTROCARDMYOP
SEX
INCLUDE	I9_HEARTFAIL
PRE_CONDITIONS
CONDITIONS	!I9_HYPERTROCARDMYOP
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to All-cause Heart Failure based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Non-ischemic cardiomyopathy

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	484404	256775	220183
Only index persons	302948	163636	139312
Unadjusted period prevalence (%)
Whole population	6.81	7.35	6.15
Only index persons	5.69	6.02	5.32
Median age at first event (years)
Whole population	73.77	75.78	71.55
Only index persons	74.97	77.41	72.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	38165	14668	23497
Unadjusted period prevalence (%)	8.30	5.00	10.36
Median age at first event (years)	71.45	72.14	71.02

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14457: Matched controls
126876

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S97

ICPC

Chronic ulcer skin

4.6

323.0

1450

3009

I42.0

ICD-10 Finland

Dilated cardiomyopathy

48.2

323.0

2117

449

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.6

323.0

2158

4667

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

6.1

323.0

1670

2673

C01BD01

ATC

amiodarone; systemic

12.5

323.0

1361

1044

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.9

323.0

5171

20203

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.0

323.0

5189

15574

I48.2

ICD-10 Finland

Chronic atrial fibrillation

10.6

323.0

998

883

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.6

323.0

1782

4781

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

5.2

323.0

4195

9247

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.5

323.0

5720

15969

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.3

323.0

2158

4941

C08CA01

ATC

amlodipine; oral

2.1

323.0

6521

36044

B01AF02

ATC

apixaban; oral

4.6

323.0

2839

6332

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

323.0

3599

12393

C01AA05

ATC

digoxin; systemic

14.9

323.0

2902

2105

C09DX04

ATC

valsartan and sacubitril; oral

318.7

323.0

697

K77

ICPC

Heart failure

28.9

323.0

784

251

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

19.6

323.0

785

371

TK800

NOMESCO Finland

Hemodialysis

8.6

323.0

853

919

AA1AD

NOMESCO Finland

CT of head and brain

2.2

323.0

4312

20336

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

323.0

3180

12334

C03CA01

ATC

furosemide; systemic

25.1

323.0

11389

16352

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

360.7

323.0

633

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.6

323.0

5304

23471

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.7

323.0

1623

4163

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

323.0

1667

4021

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.2

323.0

1110

2009

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.0

323.0

9784

43446

K78

ICPC

Atrial fibrillation/flutter

4.9

323.0

2199

4509

WX872

NOMESCO Finland

Intensive care

5.0

323.0

1676

3240

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

5.6

323.0

5722

13232

J96.1

ICD-10 Finland

Chronic respiratory failure

12.1

323.0

708

538

I48.1

ICD-10 Finland

Persistent atrial fibrillation

9.2

323.0

1032

1049

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

6.2

323.0

1145

1723

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

9.4

323.0

771

758

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

323.0

2100

5956

I50.0

ICD-10 Finland

Congestive heart failure

409.8

323.0

4829

155

103

Kela drug reimbursment

Diabetes, insulin-treated

2.8

323.0

5712

24146

XF404

NOMESCO Finland

Ambulatory ECG

3.9

323.0

2449

6354

N17.9

ICD-10 Finland

Acute renal failure, unspecified

7.4

323.0

1237

1581

R06.0

ICD-10 Finland

Dyspnoea

4.2

323.0

6121

19056

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

3.6

323.0

4108

12616

207

Kela drug reimbursment

Chronic arrhythmias

6.5

323.0

5156

9908

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

7.9

323.0

879

1035

A10BA02

ATC

metformin; oral

2.4

323.0

5540

25955

R03BB04

ATC

tiotropium bromide; inhalant

3.3

323.0

2154

6328

N18.8

ICD-10 Finland

Other chronic renal failure

7.3

323.0

839

1061

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.9

323.0

2475

6305

I50.9

ICD-10 Finland

Heart failure, unspecified

618.1

323.0

10948

637

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

323.0

2796

10263

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

5.5

323.0

4900

10787

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.1

323.0

2609

6501

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

4.2

323.0

1807

4203

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.5

323.0

3265

13366

C07AB07

ATC

bisoprolol; oral

7.5

323.0

11674

45344

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

6.2

323.0

1072

1607

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

10.0

323.0

1866

1846

B01AC04

ATC

clopidogrel; oral

2.8

323.0

3455

12698

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.4

323.0

2190

4930

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.7

323.0

1677

2429

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

323.0

4233

16893

TFP20

NOMESCO Finland

Cardiodefibrillation

5.8

323.0

2744

4892

R02

ICPC

Shortness of breath/dyspnoea

3.5

323.0

2688

7780

I35.0

ICD-10 Finland

Aortic (valve) stenosis

4.4

323.0

1329

2875

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

6.3

323.0

1242

1858

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.8

323.0

7080

17878

C09AA05

ATC

ramipril; oral

4.5

323.0

6859

21213

B01AA03

ATC

warfarin; systemic

6.6

323.0

6125

12645

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

26.7

323.0

932

326

I50

ICD-10 Finland

Heart failure

37.4

323.0

1362

352

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

6.3

323.0

7455

18255

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

4.3

323.0

1653

3720

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.1

323.0

1413

3229

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.0

323.0

2036

5011

M10.9

ICD-10 Finland

Gout, unspecified

3.8

323.0

1679

4220

I25.2

ICD-10 Finland

Old myocardial infarction

6.1

323.0

1921

3124

H02AB06

ATC

prednisolone; systemic

2.1

323.0

7554

43071

C01DA14

ATC

isosorbide mononitrate; oral

3.6

323.0

3110

8865

AN1

Coronary angiography

5.0

323.0

3732

8285

TPH07

NOMESCO Finland

Cathetrisation of artery

3.4

323.0

2583

7639

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.8

323.0

5130

11010

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.6

323.0

2508

6998

A46

ICD-10 Finland

Erysipelas

3.2

323.0

3220

10294

205

Kela drug reimbursment

Chronic hypertension

2.4

323.0

5473

25312

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.0

323.0

4916

18697

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

323.0

10476

64679

I50.1

ICD-10 Finland

Left ventricular failure

1547.0

323.0

3878

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

9.5

323.0

2490

2730

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

5.4

323.0

2233

4168

A10AE04

ATC

insulin glargine; parenteral

3.8

323.0

2377

6171

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.0

323.0

3775

10183

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

5.9

323.0

1365

2192

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

7.0

323.0

1724

2393

WX892

NOMESCO Finland

Monitored bed care

4.2

323.0

2060

4827

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

323.0

2644

9461

T90

ICPC

Diabetes non-insulin dependent

2.3

323.0

4783

22238

C03DA01

ATC

spironolactone; oral

14.0

323.0

5224

4934

M04AA01

ATC

allopurinol; systemic

3.6

323.0

3221

9240

A28

ICPC

Limited function/disability NOS

3.0

323.0

2736

9293

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

18.3

323.0

573

286

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

4.6

323.0

1355

2769

I48

ICD-10 Finland

Atrial fibrillation and flutter

7.2

323.0

7195

15296

201

Kela drug reimbursment

Chronic cardiac insufficiency

66.6

323.0

3033

503

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

8.8

323.0

795

836

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

338.2

323.0

772

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

251.9

323.0

1354

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.0

323.0

2223

5565

I47.2

ICD-10 Finland

Ventricular tachycardia

11.1

323.0

788

653

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

8.3

323.0

1376

1581

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.4

319.3

1284

2749

C10AA05

ATC

atorvastatin; oral

2.0

314.5

7102

41769

C07AB02

ATC

metoprolol; systemic

2.3

312.9

3603

15910

B01AB05

ATC

enoxaparin; parenteral

2.1

312.8

5416

28674

E66.01

ICD-10 Finland

Obesity due to excess calories

3.8

310.2

1496

3778

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.6

296.3

1502

3947

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

7.5

291.3

740

902

ZX120

NOMESCO Finland

Intravenous

3.0

287.4

1952

6354

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

4.2

285.5

1200

2671

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

8.6

284.6

664

706

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

9.0

284.2

646

657

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

5.1

282.4

967

1741

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.6

282.0

1424

3723

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

3.4

279.0

1538

4308

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

41.7

278.7

366

R60.0

ICD-10 Finland

Localized oedema

2.7

277.8

2147

7572

N19

ICD-10 Finland

Unspecified kidney failure

6.0

277.2

827

1261

C10AA01

ATC

simvastatin; oral

1.9

275.6

7626

47370

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.0

275.5

1224

2864

A11CC03

ATC

alfacalcidol; systemic

7.2

271.9

712

907

J01MA12

ATC

levofloxacin; systemic

2.2

270.7

3325

14975

SPAT1262

SPAT

Handing over of treatment supplies

2.2

270.5

3518

16264

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

268.8

4903

26082

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.4

268.1

1075

2282

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

4.1

264.1

1145

2617

J01FF01

ATC

clindamycin; systemic

2.0

262.5

4458

23012

A10BH05

ATC

linagliptin; oral

4.1

261.2

1135

2598

Angiography of the heart and coronary arteries

3.6

260.7

1308

3392

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

6.0

260.7

780

1192

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

258.8

2063

7387

WX722

NOMESCO Finland

PEEP

3.8

254.2

1214

3019

A10AE05

ATC

insulin detemir; parenteral

3.7

252.0

1214

3040

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.1

251.9

865

1558

C09AA02

ATC

enalapril; systemic

2.1

249.7

3530

16828

R4110

NOMESCO Finland

Physiotherapy

2.0

248.8

4493

23644

E66.00

ICD-10 Finland

Metabolic syndrome

3.5

248.5

1278

3376

GD1LA

NOMESCO Finland

10.4

248.4

520

454

SPAT1254

SPAT

Administration of medicine

2.4

247.1

2393

9531

A12BA01

ATC

potassium chloride; oral

4.9

245.6

876

1644

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

23.9

245.4

369

139

R03AC02

ATC

salbutamol; inhalant

1.8

244.9

7394

46511

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

244.0

4767

25793

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

239.3

2112

7989

L28

ICPC

Limited function/disability (L)

2.3

237.4

2585

10902

TKC20

NOMESCO Finland

Catheterisation of bladder

3.2

237.0

1428

4246

A02BC02

ATC

pantoprazole; systemic

1.8

236.0

9749

67540

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

10.9

235.8

481

399

N02AA05

ATC

oxycodone; systemic

2.3

234.1

2524

10586

A10BB12

ATC

glimepiride; oral

3.1

231.0

1428

4320

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

13.1

230.5

431

297

1CX08

NOMESCO Finland

72.6

230.4

276

Z49.1

ICD-10 Finland

Extracorporeal dialysis

9.3

230.2

511

497

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

71.8

227.6

273

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

225.7

2094

8114

A41.9

ICD-10 Finland

Sepsis, unspecified

4.8

225.4

827

1597

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

9.1

225.3

506

502

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

10.1

224.0

476

427

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

222.9

2828

12768

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

8.0

220.8

536

606

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

220.5

2772

12454

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

12.2

216.4

417

307

I44.2

ICD-10 Finland

Atrioventricular block, complete

6.5

216.2

607

850

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

3.2

216.1

1267

3683

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.5

215.8

1143

3078

A10BH01

ATC

sitagliptin; oral

2.5

212.4

1956

7533

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

3.0

211.0

1344

4139

R50.9

ICD-10 Finland

Fever, unspecified

2.3

209.9

2258

9408

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.3

209.8

541

671

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

93.5

207.6

241

E66.8

ICD-10 Finland

Other obesity

3.9

206.9

938

2217

B03XA02

ATC

darbepoetin alfa; parenteral

6.9

205.1

550

722

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.2

203.9

684

1195

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

6.9

202.6

543

712

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.8

199.3

725

1384

N02BE01

ATC

paracetamol; systemic, rectal

2.0

199.1

12545

96729

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

8.6

197.6

460

485

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

197.1

4777

27344

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

196.6

2396

10555

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

30.2

196.6

277

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

4.0

195.0

858

1972

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

9.5

192.6

423

403

C02AC05

ATC

moxonidine; oral

3.4

191.6

1041

2850

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.3

191.3

777

1657

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

5.1

189.1

649

1162

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.0

188.9

2878

13909

G47.3

ICD-10 Finland

Sleep apnoea

1.9

188.9

3728

19848

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

16.2

187.6

321

178

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

3.1

186.5

1144

3420

NHQ40

NOMESCO Finland

Amputation of toe

7.3

186.5

482

599

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

186.4

2138

9137

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.1

185.7

1166

3543

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.4

184.2

735

1540

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3.7

183.9

873

2142

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.5

183.4

705

1423

J96.0

ICD-10 Finland

Acute respiratory failure

10.5

182.9

380

326

A12AA04

ATC

calcium carbonate; oral

7.3

182.9

470

579

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.2

182.8

1090

3193

N02AX02

ATC

tramadol; systemic, rectal

1.7

178.8

6443

41203

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.9

178.4

1231

3978

R53

ICD-10 Finland

Malaise and fatigue

2.0

176.2

2734

13262

E66.9

ICD-10 Finland

Obesity, unspecified

4.4

176.1

687

1407

I20.09

ICD-10 Finland

Unstable angina

3.0

175.6

1103

3347

J01DB01

ATC

cefalexin; oral

1.8

175.0

11668

88574

E87.5

ICD-10 Finland

Hyperkalaemia

7.8

174.6

430

496

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.3

172.5

565

958

SPAT1263

SPAT

Sampling

1.7

171.7

6142

39037

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

171.4

1566

5958

I49.5

ICD-10 Finland

Sick sinus syndrome

4.1

170.6

729

1628

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

170.0

4281

24531

V03AE01

ATC

polystyrene sulfonate; oral

9.0

168.8

380

378

A06AD11

ATC

lactulose; oral

2.2

168.6

2044

8922

K07

ICPC

Swollen ankles/oedema

3.5

168.4

878

2322

AP1

Catheterization of the left side of the heart

6.4

167.9

475

670

127

Kela drug reimbursment

Transplant complication

6.4

167.1

473

668

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.2

166.9

986

2863

SPAT1229

SPAT

Assessment of need for aid

2.6

165.7

1376

4961

C08DB01

ATC

diltiazem; oral

3.3

163.9

906

2505

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.5

163.7

848

2230

XF600

NOMESCO Finland

Bloodpressure measurement

2.8

163.2

1162

3823

J01MA14

ATC

moxifloxacin; systemic

2.4

162.8

1522

5852

C07AG02

ATC

carvedilol; oral

2.8

162.0

1182

3947

XF640

NOMESCO Finland

4.1

161.2

682

1508

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

30.5

160.9

226

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.3

160.7

379

408

A10BK01

ATC

dapagliflozin; oral

3.1

159.6

967

2855

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

158.2

2584

12721

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

157.3

1756

7362

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.2

157.3

331

291

K84

ICPC

Heart disease other

4.3

157.2

637

1352

A08

ICPC

Swelling

3.5

156.5

818

2165

L04AA06

ATC

mycophenolic acid; systemic

5.6

156.4

491

791

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

156.1

2738

13831

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

3.1

155.8

964

2888

N18.0

ICD-10 Finland

End-stage renal disease

8.7

155.7

358

369

XG466

NOMESCO Finland

Sleep oxymetry

3.7

154.9

753

1880

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

154.4

4283

25105

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

24.6

154.0

229

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

153.9

818

2193

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.8

153.7

1132

3796

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

153.5

2402

11614

R04.0

ICD-10 Finland

Epistaxis

2.6

151.3

1270

4595

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.2

151.2

620

1330

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

150.6

1894

8370

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

150.1

4261

25099

K99

ICPC

Cardiovascular disease other

4.2

149.2

610

1305

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.9

148.9

1021

3272

I34.1

ICD-10 Finland

Mitral (valve) prolapse

4.1

148.2

625

1376

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

5.2

147.8

492

849

250

Kela drug reimbursment

235.7

147.6

159

A10BB01

ATC

glibenclamide; oral

4.1

147.4

625

1383

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

146.9

4769

29133

XF402

NOMESCO Finland

ECG with work load test

2.0

146.7

2062

9539

AA1

Conventional CABG

5.5

146.5

469

773

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

146.2

1501

6033

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

144.8

4116

24201

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

22.9

144.4

219

C07AA07

ATC

sotalol; systemic

3.6

143.7

701

1753

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.8

143.1

1017

3330

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.8

142.8

662

1586

TFP34

NOMESCO Finland

Electrophysiological investigation

3.7

142.6

689

1709

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.4

142.3

564

1170

WX882

NOMESCO Finland

High dependency care

4.0

141.4

617

1401

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

141.2

1391

5470

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

4.0

140.8

608

1368

A10BK03

ATC

empagliflozin; oral

2.3

138.6

1424

5715

WX725

NOMESCO Finland

Noninvasive ventilation

3.0

138.6

901

2785

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

137.9

2063

9763

SPAT1255

SPAT

Intravenous administration of medicine

2.5

137.9

1170

4250

I42.8

ICD-10 Finland

Other cardiomyopathies

18.0

137.7

226

112

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

137.1

1708

7491

B01AF01

ATC

rivaroxaban; oral

2.0

135.1

2146

10384

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.7

134.8

998

3348

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

4.6

134.3

501

978

C03AA03

ATC

hydrochlorothiazide; oral

2.2

134.0

1624

7034

GD1AD

NOMESCO Finland

Thorax CT examination

2.9

133.2

901

2857

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.8

131.8

478

906

C07AB03

ATC

atenolol; systemic

2.6

130.2

1019

3530

C08CA02

ATC

felodipine; oral

2.2

130.1

1576

6819

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

5.2

130.0

437

762

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

129.4

1777

8107

M10

ICD-10 Finland

Gout

2.9

129.2

889

2846

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.9

129.2

851

2651

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

12.9

128.9

241

166

WX730

NOMESCO Finland

Conventional respirator

5.7

128.9

398

628

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.9

128.3

448

815

N17.8

ICD-10 Finland

Other acute renal failure

7.7

127.7

317

370

A10AA02

ATC

4.0

126.7

548

1233

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

126.5

1807

8373

AN4

Balloon angioplasty and drug eluding stent

3.2

125.9

737

2115

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

6.3

125.8

359

512

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

6.9

125.0

334

435

M10.0

ICD-10 Finland

Idiopathic gout

3.3

124.9

675

1828

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

7.6

124.7

312

369

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

4.4

124.4

483

981

N05CF01

ATC

zopiclone; oral

1.6

122.4

4449

27662

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

122.4

1314

5371

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.4

121.6

309

374

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.6

121.2

456

897

C09CA01

ATC

losartan; oral

1.6

120.5

3769

22516

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.8

120.4

546

1281

A04

ICPC

Weakness/tiredness general

2.1

120.1

1633

7406

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

119.1

801

2524

Z94.0

ICD-10 Finland

Kidney transplant status

6.6

119.1

328

446

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

118.3

1655

7591

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.3

118.0

1219

4889

3AC01

NOMESCO Finland

7.5

117.0

294

350

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.7

116.8

429

823

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

9.0

116.4

261

258

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.8

116.3

355

552

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

116.2

831

2724

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.9

115.5

764

2383

C09CA03

ATC

valsartan; oral

2.1

115.1

1539

6924

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

115.0

901

3118

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

113.8

5208

34077

A10BJ02

ATC

liraglutide; parenteral

3.7

113.8

534

1290

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.5

113.7

589

1542

137

Kela drug reimbursment

Uraemia requiring dialysis

8.5

113.5

264

278

160

Kela drug reimbursment

exenatide

3.9

113.3

502

1154

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

5.5

113.1

358

582

TK810

NOMESCO Finland

Hemofiltration

9.9

112.7

240

216

B01AE07

ATC

dabigatran etexilate; oral

2.8

112.4

792

2571

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

112.4

10392

101705

WW500

NOMESCO Finland

Blood transfusion

2.9

112.2

731

2256

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.5

112.0

579

1514

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

7.5

111.5

281

336

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

111.5

780

2521

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

9.1

111.0

247

241

C08CA13

ATC

lercanidipine; oral

1.8

110.8

2130

10961

S18

ICPC

Laceration/cut

1.5

110.3

6342

43560

Z94.1

ICD-10 Finland

Heart transplant status

36.4

110.1

148

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.4

110.1

1043

4002

E86

ICD-10 Finland

Volume depletion

4.6

109.7

413

813

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.4

109.7

256

271

SPAT1301

SPAT

No procedures

1.6

109.5

4450

28251

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

109.5

1003

3781

SPAT1216

SPAT

Assessment of functional ability

1.8

108.9

2199

11493

J94.8

ICD-10 Finland

Other specified pleural conditions

5.4

108.8

352

587

JN4AD

NOMESCO Finland

Body CT examination

2.1

108.6

1400

6193

J81

ICD-10 Finland

Pulmonary oedema

27.1

108.1

156

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

108.1

2040

10423

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.0

108.1

694

2121

R55

ICD-10 Finland

Syncope and collapse

2.0

107.7

1557

7218

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.7

107.4

504

1217

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

107.0

996

3784

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.1

106.4

213

170

H3601, E113

ICD-10 Finland

4.9

105.8

368

666

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

5.1

105.8

356

621

I20.01

ICD-10 Finland

Unstable angina

3.3

105.5

585

1613

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.6

104.7

327

523

C10AX09

ATC

ezetimibe; oral

1.8

104.6

1997

10231

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.5

103.8

534

1390

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

7.3

103.4

263

319

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

102.5

1070

4302

I20.00

ICD-10 Finland

Unstable angina

3.4

101.4

540

1444

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

101.2

969

3732

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.0

100.5

634

1912

J46

ICD-10 Finland

Status asthmaticus

3.8

100.3

456

1072

UJF32

NOMESCO Finland

Coloscopy

1.6

100.1

3816

23740

H3603, E103

ICD-10 Finland

7.3

100.1

255

310

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

11.5

99.3

195

150

SPAT1097

SPAT

Recording of ECG

1.7

99.1

2382

13105

H3600, E113

ICD-10 Finland

5.4

98.9

318

527

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

98.8

5465

36926

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

98.7

756

2577

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

6.5

98.6

272

371

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

98.6

1803

9088

Coronary artery bypass surgery

4.9

97.9

344

630

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

97.8

3356

20328

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.5

97.2

809

2891

V03AE02

ATC

sevelamer; oral

10.7

97.2

198

164

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

7.3

96.4

247

303

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

96.2

6253

43596

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

96.2

543

1515

H02AB07

ATC

prednisone; oral

1.8

96.2

1959

10230

E87.6

ICD-10 Finland

Hypokalaemia

3.1

96.0

563

1613

J01CF05

ATC

flucloxacillin; systemic

2.9

96.0

646

2033

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.1

95.9

406

895

B01AB10

ATC

tinzaparin; parenteral

2.1

95.2

1136

4847

ZZA00

NOMESCO Finland

Split skin graft

3.2

95.1

541

1519

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

94.9

1202

5264

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.7

94.8

443

1066

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

94.6

1114

4724

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

94.6

2869

16816

C02EA02

ATC

2.7

94.5

694

2307

L17

ICPC

Foot/toe symptom/complaint

1.6

94.3

3560

22037

PE1AT

NOMESCO Finland

Femoral artery PTA

5.7

94.2

288

449

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.6

94.2

349

676

J96.9

ICD-10 Finland

Respiratory failure, unspecified

11.9

94.0

182

136

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

18.7

93.1

150

K92.1

ICD-10 Finland

Melaena

2.5

92.5

795

2890

AS7

Arrhythmia pacemaker insertion VVI (R) S

33.8

92.3

126

FL1AC

NOMESCO Finland

Left cardioangiography

4.5

92.1

349

692

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

6.5

92.0

254

347

Z49.2

ICD-10 Finland

Other dialysis

8.2

91.8

217

235

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

4.4

91.5

355

720

C09BA02

ATC

enalapril and diuretics; systemic

2.0

91.5

1391

6550

J01MA02

ATC

ciprofloxacin; systemic

1.5

91.0

5332

36266

S76

ICPC

Skin infection other

2.4

90.9

836

3148

TFJ02

NOMESCO Finland

Muscle biopsy of heart

30.4

90.8

127

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

5.9

90.2

269

407

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.7

90.0

429

1049

H3603, E113

ICD-10 Finland

6.5

89.8

248

339

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

3.5

89.8

458

1184

A41.8

ICD-10 Finland

Other specified sepsis

4.5

89.6

339

671

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

89.3

6526

46297

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.9

89.1

594

1857

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.7

89.1

321

604

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

89.0

1434

6895

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

88.8

1026

4312

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.3

88.8

209

225

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

88.6

1438

6930

R04.2

ICD-10 Finland

Haemoptysis

2.9

87.8

583

1819

J01DA01

ATC

[U] cefalexin; systemic

1.4

87.0

8108

60085

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.5

86.8

430

1086

N05CD07

ATC

temazepam; oral

1.8

86.7

1722

8896

K83

ICPC

Heart valve disease NOS

5.6

86.7

270

431

SPAT1104

SPAT

Monitoring of emergency patient

2.1

86.3

1037

4432

R95

ICPC

Chron obstructive pulmonary disease

3.1

86.3

507

1456

AN3

Balloon angioplasty and metallic stent

3.1

86.2

515

1495

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

6.9

86.1

227

291

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

11.1

85.9

172

138

WX002

NOMESCO Finland

Sedation and analgesia

1.6

85.7

2918

17545

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

85.7

1846

9782

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.2

85.7

245

351

AP2

Catheterization of the right side of the heart

15.2

85.6

149

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

3.6

85.6

422

1061

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

5.1

85.4

289

508

A10AA01

ATC

3.6

85.2

416

1038

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.7

85.2

397

953

T89

ICPC

Diabetes insulin dependent

2.9

84.8

569

1786

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

84.8

5526

38221

K28

ICPC

Limited function/disability (K)

3.7

84.0

389

929

N03AX16

ATC

pregabalin; oral

1.5

83.7

3228

19982

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

6.8

83.5

224

294

R11

ICD-10 Finland

Nausea and vomiting

2.1

82.4

1005

4322

B05DA

ATC

Isotonic solutions

7.8

82.2

201

230

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.5

82.2

677

2401

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

14.2

82.2

147

AS4

Physiological pacemaker insertion DDD (R)

5.2

81.9

270

461

R18

ICD-10 Finland

Ascites

3.9

81.6

365

846

SPAT1211

SPAT

Application of soft bandage

1.9

81.6

1321

6352

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.2

81.4

268

457

SPAT1252

SPAT

Overall medication plan or its review

2.1

81.0

1045

4600

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.6

81.0

400

1007

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.9

80.4

281

512

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

80.1

691

2513

C08DA01

ATC

verapamil; systemic

2.6

79.9

620

2125

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

8.0

79.9

191

211

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

51.9

79.8

100

M01AH05

ATC

etoricoxib; oral

0.7

79.8

5677

60309

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.7

79.6

372

895

FXG00

NOMESCO Finland

Insertion and use of IABP

28.5

79.6

113

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

79.5

676

2439

WX740

NOMESCO Finland

Nitrogen oxide therapy

31.4

79.3

110

R03DA04

ATC

theophylline; systemic, rectal

2.6

79.2

639

2241

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

79.0

884

3655

XF409

NOMESCO Finland

Other special ECG

8.8

79.0

179

181

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

78.9

1950

10743

NFQ20

NOMESCO Finland

Amputation of femur

11.7

77.7

151

114

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

6.5

77.5

215

296

K29

ICPC

Cardiovascular sympt/complt other

2.4

77.1

700

2616

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

4.6

77.0

284

548

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

4.8

76.4

270

498

A10BJ06

ATC

semaglutide; parenteral

2.7

76.3

571

1917

H36.01

ICD-10 Finland

Diabetic maculopathy

5.1

76.0

256

448

B05DB

ATC

Hypertonic solutions

8.5

76.0

175

182

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.4

75.9

297

608

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

148.2

75.9

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.5

75.7

658

2403

JN4BD

NOMESCO Finland

Extensive body CT

1.7

75.5

1758

9507

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

75.1

810

3293

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

75.0

324

728

J01CA04

ATC

amoxicillin; systemic

1.4

74.9

10514

82678

SPAT1234

SPAT

Support of social functional capacity

2.5

74.3

647

2365

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

8.8

74.2

168

170

V03AE03

ATC

lanthanum carbonate; oral

12.2

74.1

141

102

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

73.9

2888

17851

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.1

73.8

447

1311

Catheterization and pressure measurement of the left side of the heart

4.2

73.7

297

626

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

3.9

73.5

326

750

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

73.5

580

2006

SPAT1251

SPAT

Organisation of medication

2.8

73.3

501

1590

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.1

73.3

302

650

196

Kela drug reimbursment

Paricalcitol and cinacalcet

9.2

73.1

161

155

J01FA06

ATC

roxithromycin; oral

1.4

73.1

5098

35404

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.5

72.9

275

543

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

7.8

72.6

177

202

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

11.7

72.4

141

107

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.8

72.2

490

1549

NGQ20

NOMESCO Finland

Amputation of lower leg

9.8

72.0

153

138

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

333.2

71.9

N05AH04

ATC

quetiapine; oral

1.7

71.9

1747

9557

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

6.1

71.6

206

298

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.4

71.5

230

382

I44.1

ICD-10 Finland

Atrioventricular block, second degree

3.8

71.5

327

773

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.6

71.4

194

260

I95.9

ICD-10 Finland

Hypotension, unspecified

4.7

71.3

259

492

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.9

71.2

471

1463

AN2

Balloon angioplasty, including several vessels

2.7

71.2

513

1682

N05BA04

ATC

oxazepam; oral

1.5

71.1

2952

18470

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.6

71.1

550

1883

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.2

70.9

291

624

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

6.3

70.9

200

282

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

68.3

70.8

PD5BD

NOMESCO Finland

Extensive CT of aorta

3.4

70.7

373

990

N30.0

ICD-10 Finland

Acute cystitis

1.7

70.6

1579

8427

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

70.4

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.9

70.3

308

701

E0000UV

ATC

1.4

70.0

4845

33523

B01AC24

ATC

ticagrelor; oral

2.4

70.0

633

2360

WX213

NOMESCO Finland

Lower leg blockade

6.7

69.8

188

249

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.4

69.7

366

968

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.4

69.7

266

532

AP3

Catheterization of the right and left side of the heart

18.2

69.6

113

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.0

68.9

426

1267

I42

ICD-10 Finland

Cardiomyopathy

34.2

68.5

ZXA00

NOMESCO Finland

Right side

1.4

68.4

3739

24732

280

Kela drug reimbursment

Clopidogrel

4.2

68.2

275

580

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

68.1

951

4311

C09AA04

ATC

perindopril; oral

2.1

68.0

815

3469

A10BX07

ATC

[U] liraglutide; parenteral

3.8

67.6

304

708

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

52.9

67.4

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

8.6

67.3

154

159

C08CA05

ATC

nifedipine; systemic

2.1

67.1

842

3654

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

44.6

67.0

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.3

66.9

265

550

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

66.8

1151

5641

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

66.7

539

1890

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

7.3

66.5

168

203

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.7

66.4

238

446

E66.0

ICD-10 Finland

Obesity due to excess calories

4.8

66.4

233

427

AP4

Myocardial biopsy

35.7

66.3

K08.3

ICD-10 Finland

Retained dental root

1.9

66.2

1028

4854

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.6

66.2

320

793

B01AB04

ATC

dalteparin; parenteral

2.2

66.0

724

2964

212

Kela drug reimbursment

Gout

3.4

65.8

339

883

AB2

AVR bio, stent

9.2

65.8

145

140

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

2.5

65.6

541

1918

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

65.5

673

2671

Z71.8

ICD-10 Finland

Other specified counselling

1.5

65.4

2817

17723

WW200

NOMESCO Finland

Immunization

2.8

65.3

450

1435

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

26.8

65.3

ZXA05

NOMESCO Finland

Left side

1.4

65.2

3448

22619

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.7

65.0

175

232

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

7.2

64.5

165

203

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.4

64.5

598

2257

SPAT1260

SPAT

Consultation of another employee

1.5

64.2

2444

14949

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.6

64.1

310

768

AC4

MVP

8.7

64.0

145

147

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

16.0

63.1

107

H02AB04

ATC

methylprednisolone; systemic

1.6

62.8

1873

10798

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

62.8

2333

14185

WZC30

NOMESCO Finland

Teaching

1.6

62.7

1977

11559

E66

ICD-10 Finland

Obesity

2.5

62.7

538

1948

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

5.0

62.4

213

379

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

62.4

162

Kela drug reimbursment

liraglutide

4.0

62.4

269

604

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.7

62.3

459

1524

N05BA01

ATC

diazepam; systemic, rectal

1.6

62.3

1724

9747

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

23.5

62.3

TGC00

NOMESCO Finland

Bronchial lavation

2.7

62.3

453

1495

R33

ICD-10 Finland

Retention of urine

1.9

62.2

1016

4881

B03XA01

ATC

erythropoietin; parenteral

6.3

62.1

175

247

3A064

NOMESCO Finland

10.6

62.0

126

105

GD1UN

NOMESCO Finland

Lung circulation SPECT

7.1

61.9

160

200

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.6

61.9

479

1638

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

61.9

3056

19743

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.4

61.8

326

866

R06.2

ICD-10 Finland

Wheezing

2.3

61.7

595

2287

L04AD01

ATC

ciclosporin; systemic

3.3

61.7

335

909

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

5.5

61.6

192

308

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

61.1

1523

8364

T92

ICPC

Gout

3.1

61.0

364

1057

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

8.2

60.7

143

155

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

7.0

60.7

158

200

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.0

60.6

258

573

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

60.6

3377

22321

B01AF03

ATC

edoxaban; oral

3.6

60.6

292

722

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.2

60.5

348

985

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

60.2

867

3974

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

6.1

59.9

172

249

N06AX11

ATC

mirtazapine; oral

1.4

59.7

3845

26083

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.6

59.6

219

422

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

59.5

1232

6403

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.2

59.3

239

505

C02CA01

ATC

prazosin; oral

4.1

59.1

245

531

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.2

58.9

237

500

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

58.8

452

1540

SPAT1151

SPAT

Treatment of major wounds

4.0

58.7

252

564

Z51.5

ICD-10 Finland

Palliative care

2.0

58.7

842

3854

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

3.2

58.7

326

900

C01BC04

ATC

flecainide; systemic

2.3

58.6

609

2430

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.7

58.5

209

391

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

58.4

2224

13575

XF622

NOMESCO Finland

Measurement of minute volume of heart

10.6

58.2

118

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

4.3

58.2

229

473

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

57.6

921

4387

Single vessel balloon catheter extension

3.1

57.3

339

978

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.1

57.2

344

1002

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

11.4

57.1

112

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

56.7

3407

37826

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

56.6

1618

9207

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.3

56.6

220

449

EBA00

NOMESCO Finland

Extraction of tooth

1.4

56.5

4098

28319

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

56.4

2233

13736

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.7

56.3

415

1379

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.1

56.1

327

934

M79.6

ICD-10 Finland

Pain in limb

1.4

56.1

4528

31842

AS2

Ventricular pacemaker insertion VVI (R)

11.1

56.0

111

A10BH02

ATC

vildagliptin; oral

3.1

56.0

334

970

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

5.0

56.0

189

333

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

15.4

55.9

C09AA01

ATC

captopril; oral

3.7

55.8

264

643

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

3.7

55.8

259

621

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.3

55.7

573

2273

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

5.7

55.2

167

259

T82

ICPC

Obesity

2.5

55.0

453

1606

A08AB01

ATC

orlistat; oral

4.7

54.9

198

375

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

7.0

54.5

142

180

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

20.3

54.5

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

20.3

54.5

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.4

54.5

500

1876

R4190

NOMESCO Finland

Nutritional therapy

2.4

54.4

479

1757

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

4.2

54.0

218

462

A10AE06

ATC

insulin degludec; parenteral

2.6

53.9

417

1427

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.5

53.7

168

271

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

10.5

53.4

109

W19

ICD-10 Finland

Unspecified fall

1.7

53.4

1139

5965

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.5

53.2

260

651

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

5.8

53.1

158

240

OAB43

SPAT

0.4

53.1

314

6003

H05BX01

ATC

cinacalcet; oral

6.3

52.8

147

205

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

52.6

898

4374

CKC12

NOMESCO Finland

Photocoagulation of retina

2.1

52.3

651

2813

CKC15

NOMESCO Finland

Panretinal photocoagulation

5.1

52.3

174

302

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.0

52.3

222

493

WX900

NOMESCO Finland

Resuscitation

10.0

52.2

109

U14

ICPC

Kidney symptom/complaint

3.6

52.1

246

599

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

4.7

52.0

187

353

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.8

52.0

351

1107

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

11.1

51.9

103

A07AA09

ATC

vancomycin; oral

4.2

51.8

210

447

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.5

51.6

252

631

RS221

NOMESCO Finland

3.7

51.4

241

583

WX110

NOMESCO Finland

Local anesthesy

1.3

51.4

8856

69321

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.6

51.3

250

625

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

51.1

4327

30545

K90

ICPC

Stroke/cerebrovascular accident

2.6

51.0

395

1353

R03BA02

ATC

budesonide; inhalant

1.5

50.9

2015

12369

E000001

ATC

1.5

50.9

2305

14555

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

75.6

50.8

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

11.9

50.6

SPAT1310

SPAT

Counselling related to known health issue

1.3

50.5

4234

29832

N05AX08

ATC

risperidone; systemic

1.9

50.4

764

3567

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

5.5

50.2

156

250

TK820

NOMESCO Finland

Peritoneal dialysis

7.4

50.1

125

149

ZX108

NOMESCO Finland

Inhalation

5.1

49.9

167

292

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.0

49.6

303

895

B82

ICPC

Anaemia other/unspecified

2.8

49.6

348

1123

WX890

NOMESCO Finland

Intesive care monitoring

6.1

49.5

142

206

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

4.6

49.5

183

356

C09CA06

ATC

candesartan; oral

1.4

49.5

2777

18264

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

7.4

49.5

123

146

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.1

49.4

577

2426

A29

ICPC

General symptom/complaint other

1.6

49.2

1360

7656

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

14.2

49.1

Catheterization and pressure measurement of the right side of the heart

9.8

48.8

103

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

48.6

997

5154

L04AX01

ATC

azathioprine; systemic

2.1

48.5

571

2408

N05AA02

ATC

levomepromazine; systemic

2.1

48.3

561

2353

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

48.3

845

4148

R31

ICD-10 Finland

Unspecified haematuria

1.6

48.3

1313

7358

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

14.4

48.3

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

15.3

48.2

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

4.1

47.9

199

434

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

10.2

47.8

I27.0

ICD-10 Finland

Primary pulmonary hypertension

16.4

47.8

TFP35

NOMESCO Finland

Electroanatomical mapping

3.2

47.8

272

765

SPAT1172

SPAT

Guidance concerning hydration

3.1

47.7

278

795

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.9

47.6

313

971

K65.0

ICD-10 Finland

Acute peritonitis

4.0

47.6

199

436

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

8.4

47.5

109

114

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.6

47.5

377

1310

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

224.8

47.5

5CM18

NOMESCO Finland

8.2

47.4

111

120

R03BA05

ATC

fluticasone; inhalant

1.5

47.3

2038

12717

J20

ICD-10 Finland

Acute bronchitis

1.7

47.3

1174

6417

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

5.2

47.2

153

258

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

47.2

879

4406

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

6.4

47.0

129

177

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

8.0

46.9

111

122

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

9.1

46.9

103

100

AB1

AVR mechanical

7.2

46.6

118

144

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

3.3

46.6

250

674

SPAT1325

SPAT

Vaccination

1.3

46.4

4650

33550

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

6.7

46.4

124

164

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

46.4

471

1859

7AX01

NOMESCO Finland

61.7

46.2

AQ1

Conventional electrophysiological examination

3.5

46.1

230

586

R03BB01

ATC

ipratropium bromide; inhalant

2.4

46.0

414

1538

5253

FHL

Cardiac lung machine

7.5

46.0

114

135

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.9

46.0

197

442

R03AC12

ATC

salmeterol; inhalant

2.1

45.9

539

2271

L04AA01

ATC

[U] ciclosporin; systemic

3.2

45.9

260

728

UJF92

NOMESCO Finland

Capsular endoscopy

2.9

45.7

297

915

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

45.7

686

3190

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

8.8

45.7

102

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.6

45.6

139

218

C10AA03

ATC

pravastatin; oral

1.7

45.6

1031

5484

342

Kela drug reimbursment

Dronedarone

4.1

45.5

186

400

RS220

NOMESCO Finland

3.8

45.5

205

481

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

15.8

45.4

C10AA04

ATC

fluvastatin; oral

1.6

45.4

1210

6742

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

45.4

3863

27180

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

45.1

1146

6299

3025

Kela drug reimbursment

Calcium carbonate

9.4

45.0

RD210

NOMESCO Finland

3.2

45.0

255

714

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.0

44.8

626

2832

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

44.8

433

1668

S20

ICPC

Corn/callosity

2.7

44.5

318

1039

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

44.4

2080

13183

R42

ICD-10 Finland

Dizziness and giddiness

1.4

44.4

2644

17528

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

44.4

802

3978

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

44.3

397

1473

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

44.2

1176

6543

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

44.0

898

4631

WX212

NOMESCO Finland

Femoral plexus blockade

3.0

43.8

269

798

742

NOMESCO Finland

10.5

43.8

H26.4

ICD-10 Finland

After-cataract

1.7

43.8

1094

5987

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

43.6

994

5300

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

5.9

43.6

128

192

D64.8

ICD-10 Finland

Other specified anaemias

3.3

43.6

237

646

N06AB04

ATC

citalopram; systemic

1.4

43.6

2481

16309

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

6.8

43.5

115

150

I11

ICD-10 Finland

Hypertensive heart disease

6.0

43.4

125

183

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

43.4

472

1921

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

5.1

43.3

143

247

I97.0

ICD-10 Finland

Postcardiotomy syndrome

6.9

43.2

113

145

PD5AD

NOMESCO Finland

CT of aorta

3.1

43.0

257

747

R03AC13

ATC

formoterol; inhalant

2.0

43.0

608

2765

M10.3

ICD-10 Finland

Gout due to impairment of renal function

7.6

42.9

105

122

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

42.9

334

1147

F05.9

ICD-10 Finland

Delirium, unspecified

3.1

42.8

251

722

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.9

42.8

275

842

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

42.7

3661

39082

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.9

42.7

273

832

S72.0

ICD-10 Finland

Fracture of neck of femur

2.4

42.7

369

1344

SPAT1167

SPAT

Insertion of urinary catheter

2.3

42.6

419

1629

X57

ICD-10 Finland

Unspecified privation

2.6

42.5

319

1074

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.0

42.5

602

2737

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

42.5

1239

7059

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.3

42.4

222

588

SPAT1281

SPAT

Other administrative function

1.7

42.4

1013

5471

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

3.9

42.3

182

410

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.6

42.3

129

203

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.7

42.3

301

982

J43.9

ICD-10 Finland

Emphysema, unspecified

3.3

42.2

227

614

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.8

42.1

279

870

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

43.2

42.1

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.2

42.0

233

645

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

23.7

41.9

ZXA10

NOMESCO Finland

Bilateral

1.4

41.9

2308

15068

R4120

NOMESCO Finland

Occupational therapy

1.8

41.7

803

4065

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.0

41.5

578

2612

TK830

NOMESCO Finland

Ultrafiltration

63.0

41.4

N18

ICD-10 Finland

Chronic kidney disease

4.7

41.4

148

279

B80

ICPC

Iron deficiency anaemia

3.1

41.4

246

715

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

41.3

893

4683

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

32.9

41.2

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

41.0

1385

8173

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

5.3

40.9

130

215

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.3

40.8

2341

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

7.1

40.8

104

129

N03AX12

ATC

gabapentin; oral

1.4

40.7

1926

12211

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

4.4

40.7

155

312

E05.89

ICD-10 Finland

Other thyrotoxicosis

9.5

40.6

R81

ICPC

Pneumonia

2.2

40.6

430

1729

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

7.2

40.5

103

127

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.9

40.5

178

409

C01BD07

ATC

dronedarone; oral

4.3

40.3

157

323

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

4.8

40.3

141

260

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.3

40.2

158

328

C02DE04

ATC

2.9

40.2

253

764

R60.1

ICD-10 Finland

Generalized oedema

5.8

40.2

119

181

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.5

40.2

125

202

A02BC01

ATC

omeprazole; systemic

1.3

40.0

3395

23782

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

40.0

596

2760

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

40.0

272

864

PD4BD

NOMESCO Finland

Extensive CT of lower extremity arteries

6.0

40.0

116

172

M86.6

ICD-10 Finland

Other chronic osteomyelitis

6.9

39.9

104

133

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.6

39.9

304

1031

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

39.8

568

2590

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.4

39.7

364

1368

J45

ICD-10 Finland

Asthma

1.6

39.6

1107

6234

H3601, E103

ICD-10 Finland

4.2

39.5

156

325

WX402

NOMESCO Finland

General anaesthesia

1.4

39.4

2116

13735

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

22.6

39.4

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

39.4

1136

6451

R41.0

ICD-10 Finland

Disorientation, unspecified

2.5

39.4

335

1210

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

39.4

997

5472

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

39.3

5732

43199

TQW80

NOMESCO Finland

Local dermatologic skincare

2.3

39.0

370

1412

B01AC07

ATC

dipyridamole; systemic

2.3

39.0

399

1578

I20.91

ICD-10 Finland

Angina pectoris, unspecified

3.4

39.0

199

518

A10BX04

ATC

[U] exenatide; parenteral

3.2

39.0

212

579

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

12.7

38.9

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.7

38.9

288

962

ZPB22

NOMESCO Finland

Autograft of vein

5.8

38.8

115

175

N05AF03

ATC

chlorprothixene; systemic

2.4

38.8

352

1315

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

5.2

38.7

125

211

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.1

38.7

128

222

C07AB05

ATC

betaxolol; oral

2.3

38.5

388

1524

E87.2

ICD-10 Finland

Acidosis

5.6

38.5

117

184

H25.8

ICD-10 Finland

Other senile cataract

1.5

38.4

1313

7765

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.0

38.3

159

348

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

38.2

4120

29829

R28

ICPC

Limited function/disability (R)

3.4

38.1

198

523

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

29.2

38.0

A10BG02

ATC

rosiglitazone; oral

2.9

37.9

240

728

288

Kela drug reimbursment

Febuxostat

6.4

37.8

104

144

A01

ICPC

Pain general/multiple sites

1.7

37.7

891

4795

H02AB09

ATC

hydrocortisone; systemic

2.5

37.5

301

1053

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

77.5

37.5

J45.8

ICD-10 Finland

Mixed asthma

2.3

37.5

371

1446

A98

ICPC

Health maint/preventive medicine

0.7

37.5

12928

117429

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

37.4

1381

8308

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.5

37.4

116

187

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

42.2

37.3

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.3

37.2

195

518

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.4

37.2

188

486

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

4.8

37.2

130

240

K87

ICPC

Hypertension complicated

2.4

37.2

326

1195

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.3

37.2

194

514

L84

ICD-10 Finland

Corns and callosities

2.1

37.1

451

1929

R4180

NOMESCO Finland

Podiatric therapy

3.5

37.1

183

464

I95.2

ICD-10 Finland

Hypotension due to drugs

5.0

37.1

124

218

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

37.0

452

1937

A10BX01

ATC

guar gum; systemic

2.0

37.0

485

2140

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.9

36.8

568

2665

A10BG03

ATC

pioglitazone; oral

2.2

36.8

399

1624

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

2.9

36.7

239

739

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.8

36.7

127

232

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

36.6

337

1268

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.0

36.5

465

2028

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.9

36.4

157

356

WX721

NOMESCO Finland

Oxygen concentrator therapy

10.4

36.3

R07.3

ICD-10 Finland

Other chest pain

1.5

36.3

1178

6880

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

4.3

36.2

142

295

K92

ICPC

Atherosclerosis/periph vascular dis

3.1

36.1

209

597

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.9

36.1

123

221

M04AA03

ATC

febuxostat; oral

6.7

36.1

127

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.5

36.0

304

1094

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

35.9

841

4512

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.0

35.9

121

215

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

35.8

832

4455

N03AG01

ATC

valproic acid; systemic, rectal

1.8

35.8

652

3243

C02DE02

ATC

3.8

35.7

161

379

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.6

35.7

272

924

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

35.7

863

4673

A10AB06

ATC

insulin glulisine; parenteral

3.5

35.6

176

447

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

5.3

35.6

114

191

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.2

35.6

143

304

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

35.5

380

1539

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.9

35.3

577

2763

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.3

35.1

185

494

K80

ICPC

Cardiac arrhythmia NOS

1.6

35.1

973

5461

L14

ICPC

Leg/thigh symptom/complaint

1.6

35.1

905

4985

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

35.1

694

3543

K92.0

ICD-10 Finland

Haematemesis

2.4

35.0

300

1088

FXZ00

NOMESCO Finland

Off-pump cardiac operation

4.7

34.9

124

233

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

11.3

34.9

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.1

34.8

141

302

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.0

34.7

210

618

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

23.6

34.6

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

34.4

579

2805

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

5.1

34.3

112

192

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.1

34.2

141

307

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.3

34.2

109

182

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

314.6

34.1

I48.3

ICD-10 Finland

Typical atrial flutter

3.9

34.1

149

342

K60

ICPC

Cardiovascular, Result test/procedure

4.0

33.9

143

318

J01AA02

ATC

doxycycline; systemic

1.3

33.9

10322

84186

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

7.2

33.8

104

R03AC03

ATC

terbutaline; inhalant

1.5

33.7

1498

9355

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

33.7

1501

9384

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

33.6

400

1696

A10BB07

ATC

glipizide; oral

3.8

33.4

148

344

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

33.4

557

2690

AC2

MVR bio

33.0

33.3

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

33.2

424

1850

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

6.7

33.2

116

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.5

33.2

277

991

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

33.2

1453

9048

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

3.6

33.2

158

390

RS222

NOMESCO Finland

3.3

33.2

173

459

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

8.0

33.2

PEN23

NOMESCO Finland

Plastic repair of femoral artery

3.6

33.1

159

396

H3600, E103

ICD-10 Finland

3.7

33.0

152

365

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.8

33.0

225

716

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

4.2

33.0

132

280

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

32.9

834

4573

RJ411

NOMESCO Finland

4.8

32.9

114

209

EBA30

NOMESCO Finland

Excision of root of tooth

1.7

32.9

698

3640

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

5.0

32.8

110

195

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.1

32.8

193

558

FXE00

NOMESCO Finland

Use of ECLA

37.8

32.8

SPAT1060

SPAT

Administration of oxygen

6.3

32.7

125

D09AB01

ATC

zinc bandage without supplements; topical

2.5

32.7

263

921

G72.8

ICD-10 Finland

Other specified myopathies

2.9

32.7

205

619

ASA

Insertion of a biventricular pacemaker VVI (R) S

+∞

32.7

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.8

32.6

112

204

R2110

NOMESCO Finland

Giving the first information

1.7

32.5

698

3651

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.5

32.5

269

959

N05AH03

ATC

olanzapine; systemic

1.8

32.4

593

2950

A03

ICPC

Fever

1.4

32.3

1464

9176

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.0

32.3

198

590

PD3AT

NOMESCO Finland

Pelvic artery PTA

4.4

32.1

122

246

K76

ICPC

Ischaemic heart dis without angina

2.2

32.1

354

1452

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.3

32.1

169

452

J04AB02

ATC

rifampicin; systemic

3.0

32.1

191

558

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

32.0

348

1420

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.7

32.0

235

784

U04

ICPC

Incontinence urine

1.9

31.9

520

2489

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

31.9

352

1444

40199

ICD-8 Finland

Essential benign hypertension

2.8

31.7

212

666

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

31.6

953

5466

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

9.2

31.5

H03BB01

ATC

carbimazole; oral

2.0

31.5

432

1941

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

5.0

31.4

104

182

-50

ICPC

Medication/prescr/renewal

1.9

31.4

519

2497

N083, E102

ICD-10 Finland

23.8

31.3

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

4.8

31.2

109

202

C09AA03

ATC

lisinopril; oral

1.7

31.2

639

3298

349

Kela drug reimbursment

Febuxostat

6.4

31.2

117

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2522

7885

2.44

322.53

6.0

3.6

48.6

47.4

1.47

2481

7805

(3002582) Erythrocytes [#/volume] in Urine

10394

52961

1.67

319.64

4.6

3.3

155.4

95.4

e6/l

1.77

8583

40612

(3043409) Potassium [Moles/volume] in Arterial blood

1847

5032

2.76

310.77

6.4

3.9

4.0

3.9

mmol/l

11.27

1717

4739

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10175

51846

1.66

310.36

3.2

2.6

55.4

60.3

u/l

12.11

9531

47327

(3026782) Osmolality of Urine

7400

34620

1.74

309.61

3.7

2.8

510.0

560.5

mosm/kgh2o

88.06

6512

29196

(3014576) Chloride [Moles/volume] in Serum or Plasma

6376

21903

2.43

307.65

10.6

6.3

103.6

104.5

mmol/l

33.07

6211

21431

(3013290) Carbon dioxide [Partial pressure] in Blood

1647

3575

3.47

307.65

6.5

3.4

5.1

5.0

kpa

6.32

1610

3488

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3554

8747

3.21

307.65

11.9

8.3

24.6

24.3

mmol/l

5.01

3266

8153

(3024354) Oxygen [Partial pressure] in Venous blood

4611

12805

2.92

307.65

4.8

2.9

4.6

4.5

kpa

0.73

4417

12438

(3014007) Fractional oxyhemoglobin in Arterial blood

3807

10660

2.83

307.65

12.8

8.1

92.5

94.2

41.79

3787

10630

(3021901) Oxygen saturation in Capillary blood

1535

2856

4.04

307.65

3.8

2.5

—

(3019198) Lymphocytes [#/volume] in Blood

15140

79324

1.84

307.65

7.3

5.7

1.7

1.9

e9/l

34.49

13444

68364

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3847

12487

2.42

307.65

5.6

3.5

135.5

86.0

ng/l

100.66

3353

10485

(42870588) Differential panel, method unspecified - Blood

11396

54860

1.85

307.65

7.1

5.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1485

3419

3.25

307.65

1.5

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

919

1364

4.99

307.65

1.4

1.3

7.2

5.8

mmol/l

29.07

867

1248

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1617

3632

3.35

307.65

1.7

1.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

953

1405

5.03

307.65

1.4

1.3

343.6

588.2

u/l

1.86

903

1331

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2940

2328

10.07

307.65

3.4

2.8

0.8

nmol/l

5.34

2359

1709

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3638

9787

2.93

307.65

10.4

6.4

25.0

24.7

mmol/l

2.34

3599

9698

(3018010) Neutrophils/100 leukocytes in Blood

13988

73474

1.76

307.65

7.5

5.8

62.7

57.7

307.65

13247

67808

(3023199) Leukocytes [#/volume] in Pleural fluid

1298

1765

5.51

307.65

1.6

1.4

2510.6

3438.5

e6/l

0.51

952

1284

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

17843

50564

5.41

307.65

5.9

2.2

3360.2

889.2

ng/l

307.65

16719

42846

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3268

5268

4.94

307.65

3.9

2.7

0.3

0.4

u/ml

1.06

2093

2869

(3016502) Oxygen saturation in Arterial blood

6475

17195

3.24

307.65

10.1

6.9

94.0

96.0

75.43

6243

16559

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2232

5923

2.87

307.65

3.2

2.1

468.2

612.6

ug/l

1.43

2155

5564

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3941

9838

3.20

307.65

5.7

3.2

2.5

1.5

mmol/l

32.13

3053

7212

(3001604) Monocytes [#/volume] in Blood

14938

77365

1.86

307.65

7.1

5.6

0.7

0.6

e9/l

108.71

13120

65469

(3003396) Base excess in Arterial blood by calculation

7142

19095

3.29

307.65

9.8

6.5

1.5

0.9

mmol/l

20.34

5761

15018

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9259

22573

3.95

307.65

3.7

2.3

g/l

0.50

8728

20582

(3019060) Gas panel - Arterial blood

4569

10870

3.43

307.65

5.9

4.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2269

6601

2.61

307.65

7.0

3.5

25.2

24.7

mmol/l

7.00

2140

6000

(3019069) Monocytes/100 leukocytes in Blood

14130

73161

1.81

307.65

8.0

6.2

9.1

8.9

6.57

13414

67613

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3819

10592

2.86

307.65

12.7

8.0

0.6

0.7

9.34

3793

10524

(3012544) pH of Venous blood

6051

15957

3.22

307.65

5.9

3.4

7.4

0.92

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3086

9313

2.56

307.65

14.4

8.6

—

(3013115) Eosinophils [#/volume] in Blood

15298

80200

1.85

307.65

7.4

5.9

0.2

e9/l

1.44

13548

68918

(3026008) Bacteria identified in Urine by Culture

10945

51700

1.87

307.65

4.1

3.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

5225

18328

2.30

307.65

2.4

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3489

9275

2.96

307.65

1.7

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

5210

14669

2.92

307.65

10.0

6.2

1.5

1.3

mmol/l

10.96

4986

14145

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16731

86640

2.00

307.65

12.5

6.3

1.2

mmol/l

270.23

14207

72405

(40768806) Pleura Pathology biopsy report

1066

1603

4.94

307.65

1.6

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3284

7376

3.51

307.65

6.1

3.8

24.2

24.0

mmol/l

1.68

2940

6619

(1616796) Gas panel - Central venous blood

1735

3445

3.81

307.65

5.5

3.1

—

(3006315) Basophils [#/volume] in Blood

15018

77853

1.86

307.65

7.1

5.7

0.0

e9/l

0.04

13207

65953

(3022313) Gas panel - Capillary blood

2824

7493

2.91

307.65

6.2

3.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1516

3192

3.56

307.65

2.7

2.5

33.0

33.8

umol/l

0.48

1281

2657

(3032080) INR in Blood by Coagulation assay

16538

72328

2.63

307.65

20.3

8.3

1.6

1.3

inr

116.58

4832

19511

(3027945) Reticulocytes/100 erythrocytes in Blood

6378

20048

2.68

307.65

2.8

2.4

2.0

1.7

61.12

5745

17461

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5898

15327

3.26

307.65

5.9

3.4

6.0

5.8

kpa

43.88

5702

14934

(3004588) Protein electrophoresis panel - Serum or Plasma

3652

12501

2.27

307.65

2.2

2.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2598

7845

2.53

307.65

4.3

2.5

0.7

0.30

2528

7504

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7485

21051

3.15

307.65

9.0

5.2

1.1

1.0

mmol/l

137.20

7021

19399

(3023368) Bacteria identified in Blood by Culture

13328

47343

3.00

307.65

6.2

4.1

—

(3009343) pH of Capillary blood

4044

10224

3.17

307.65

5.8

3.2

7.4

4.54

620

1275

(3013650) Neutrophils [#/volume] in Blood by Automated count

16372

90639

1.75

307.65

10.3

9.0

5.0

4.2

e9/l

215.28

14580

78101

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10712

53120

1.74

307.65

2.7

2.1

237.8

220.6

u/l

0.49

10072

49411

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5329

15243

2.88

307.65

3.1

2.2

9.4

7.0

ug/l

6.32

4664

13117

(3000991) Gas panel - Venous blood

5274

13723

3.19

307.65

11.8

7.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

7175

19080

3.31

307.65

9.7

6.5

10.5

12.6

kpa

228.79

6797

18214

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2157

5717

2.86

307.65

2.7

3.5

57.0

43.3

mg/l

1.37

1723

4649

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2320

6808

2.59

307.65

1.4

1.6

14.5

16.2

u/ml

0.15

173

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1549

3516

3.30

307.65

1.7

1.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

14236

74648

1.78

307.65

7.8

6.1

21.7

27.1

307.65

13441

68548

(3003434) Protein [Mass/volume] in Pleural fluid

1484

1971

5.68

307.65

1.6

1.4

26.9

36.6

g/l

115.35

1271

1827

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3803

10648

2.83

307.65

12.5

8.0

1.5

1.3

14.15

3776

10574

(3002032) Base excess in Venous blood by calculation

5876

15304

3.25

307.65

5.9

3.4

2.2

1.7

mmol/l

12.27

4906

12422

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6380

18659

2.91

307.65

2.2

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4088

10358

3.17

307.65

5.8

3.2

5.3

5.1

kpa

23.42

3839

9455

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6378

18605

2.91

307.65

2.2

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3482

7648

3.61

307.65

1.8

1.6

g/l

0.09

2992

6467

(3020779) Urea [Moles/volume] in Serum or Plasma

6445

14212

3.96

307.65

11.5

6.0

13.5

9.5

mmol/l

230.42

6141

13423

(40760888) Immunoglobulin light chains.free panel - Serum

1684

4229

2.99

307.65

2.8

3.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2113

5545

2.89

307.65

2.6

3.4

7.0

4.5

ratio

0.32

165

411

(3020891) Body temperature

2360

6671

2.69

307.65

7.3

4.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5589

15940

2.92

307.65

11.1

7.2

118.9

121.3

g/l

12.44

5456

15332

(3004119) Hemoglobin [Mass/volume] in Venous blood

3405

10445

2.54

307.65

5.3

3.0

122.0

129.4

g/l

56.35

3304

10202

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8062

31941

2.16

307.65

2.7

1.6

1.5

1.4

mg/l

0.99

6649

24688

(3010421) pH of Blood

1835

4132

3.36

307.65

6.5

3.4

7.4

3.07

1613

3489

(3018405) Lactate [Moles/volume] in Arterial blood

2209

5826

2.88

307.65

5.8

3.7

1.5

1.4

mmol/l

3.10

2161

5730

(3022948) Iron [Moles/volume] in Serum or Plasma

9625

24472

3.82

307.65

3.7

2.3

11.0

12.9

umol/l

107.35

9065

22359

(3012501) Base excess in Blood by calculation

1645

3575

3.46

307.65

6.5

3.4

3.1

2.4

mmol/l

13.09

1202

2409

(3026493) Urate [Moles/volume] in Serum or Plasma

9563

43447

1.90

307.65

4.0

2.7

4464.7

5868.1

umol/l

2.17

8237

36784

(3012441) Differential panel - Pleural fluid

1137

1526

5.56

307.65

1.6

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4736

14634

2.61

307.65

2.3

2.6

64.5

66.6

g/l

53.02

4344

13083

(3019309) Folate [Moles/volume] in Red Blood Cells

8083

35274

1.92

307.65

2.0

1.7

1233.0

1139.3

nmol/l

12.99

6341

25833

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

14723

65741

2.32

307.65

6.9

3.4

109.8

62.9

ng/l

2.90

12544

49406

(3006504) Eosinophils/100 leukocytes in Blood

14066

72761

1.81

307.65

7.6

5.9

2.6

2.9

34.33

13331

67007

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1485

3418

3.25

307.65

1.5

1.3

—

(3024928) Oxygen saturation in Venous blood

1492

3250

3.44

307.65

4.4

3.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

15062

74119

2.03

307.65

6.9

4.6

32.6

35.1

g/l

307.65

14134

68104

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3967

11894

2.64

307.65

1.9

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1910

4726

3.05

307.65

1.4

1.3

—

(3018418) pH of Serum or Plasma

10453

51035

1.77

307.65

6.5

3.9

7.4

0.43

2389

9419

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6429

19964

2.72

307.65

4.5

4.2

262.6

243.8

u/l

14.05

6090

18805

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8968

21119

4.06

307.65

3.7

2.3

19.6

23.0

84.12

7784

17652

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8947

27203

3.03

307.65

2.3

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7112

26558

2.25

307.65

3.2

1.9

31.6

29.6

96.47

6892

25785

(40767503) Oxygen content in Capillary blood by calculation

1547

3437

3.38

307.65

3.6

2.2

15.4

16.4

13.46

862

1782

(3034860) Kappa light chains.free [Mass/volume] in Serum

2156

5727

2.86

307.65

2.7

3.5

72.6

68.4

mg/l

0.14

1730

4644

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4249

15408

2.17

307.65

2.2

0.2

g/l

63.28

3832

14290

(3027315) Oxygen [Partial pressure] in Blood

1673

3586

3.51

307.65

6.5

3.4

8.1

8.6

kpa

17.46

1636

3498

(3028626) Oxygen [Partial pressure] in Capillary blood

1810

3449

3.98

307.65

4.1

3.0

7.8

8.1

kpa

13.00

1701

3177

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7180

19093

3.32

307.65

9.7

6.5

5.2

5.1

kpa

11.53

6819

18230

(3023520) Reticulocytes [#/volume] in Blood

4921

15200

2.62

307.65

2.9

2.5

73.9

67.0

e9/l

26.82

3828

11571

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3390

10418

2.53

307.65

2.1

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11501

40968

2.76

307.65

3.0

2.1

3.5

2.9

mg/l

83.31

10217

34212

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

16931

85918

2.10

307.65

7.8

6.3

13.6

11.9

umol/l

43.26

16270

81241

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3725

10537

2.79

307.65

10.0

6.4

24.8

24.5

mmol/l

2.57

3546

9781

(3000850) Epithelial cells [#/volume] in Urine

7836

36810

1.75

307.65

3.6

2.6

5.3

4.7

e6/l

3.72

7035

31990

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2851

6897

3.21

307.65

2.2

1.9

2.9

2.2

ug/l

0.61

2553

5990

(3022096) Basophils/100 leukocytes in Blood

13813

70732

1.82

307.65

7.6

5.9

0.6

0.7

34.07

13103

65212

(3027273) Bicarbonate [Moles/volume] in Venous blood

2890

8396

2.65

307.65

5.4

3.1

25.4

25.1

mmol/l

2.98

2802

8168

(3045788) Cell count panel - Pleural fluid

1002

1349

5.52

307.65

1.6

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

7991

23141

3.10

307.65

41.1

23.9

1.8

1.4

inr

61.27

942

3256

(3013826) Glucose [Moles/volume] in Serum or Plasma

18449

99055

2.04

307.65

9.2

4.4

7.3

6.8

mmol/l

149.15

17809

92947

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1939

4003

3.68

307.65

4.3

2.7

25.2

24.6

mmol/l

5.19

1732

3502

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15559

78795

1.98

307.65

11.5

5.6

1.2

mmol/l

268.95

14475

70335

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1821

4675

2.93

307.65

2.0

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8816

33120

2.35

307.65

6.7

3.4

678.9

467.3

ng/l

1.28

8267

27476

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8269

26311

2.81

307.65

4.3

3.2

0.8

mmol/l

0.74

7765

24311

(3001122) Ferritin [Mass/volume] in Serum or Plasma

13688

58848

2.35

307.65

4.3

2.6

181.4

163.2

ug/l

3.22

12796

52883

(3028308) Erythrocytes [#/volume] in Pleural fluid

1185

1601

5.53

307.65

1.5

1.4

56563.6

65248.2

e6/l

0.31

719

965

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

6354

14126

3.92

307.65

4.9

2.2

447.4

121.0

ng/l

247.90

6010

12850

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2675

8003

2.56

307.65

4.3

2.5

1.3

1.2

9.19

2659

7965

(3042936) Bacteria identified in Isolate by Culture

6642

22738

2.46

307.65

2.7

1.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2055

6053

2.56

296.72

2.7

2.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1013

1959

3.83

294.13

2.3

1.7

88.5

89.6

4.73

1000

1929

(3028271) Lactate [Moles/volume] in Capillary blood

1169

2528

3.43

289.16

2.5

1.7

mmol/l

0.22

1150

2461

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9472

48041

1.64

288.66

3.6

3.2

42.3

35.2

u/l

3.58

8957

45113

(3021960) Folate [Moles/volume] in Serum or Plasma

8557

42308

1.66

287.80

1.8

1.5

18.9

20.5

nmol/l

17.03

7580

35373

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1207

2694

3.33

284.44

1.7

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1069

2205

3.59

283.43

7.4

5.9

12.1

11.9

mg/l

0.66

972

2014

(3044640) Blood type and Crossmatch panel - Blood

10108

52283

1.62

283.40

3.5

2.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1539

4035

2.85

277.07

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

737

1161

4.67

276.71

1.4

1.3

11.3

14.9

u/l

2.60

642

1102

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1557

4113

2.83

276.51

3.5

2.3

3.7

3.6

g/l

1.45

1496

3936

(3030467) Casts [#/volume] in Urine by Automated count

9504

48848

1.61

269.94

4.4

3.2

0.8

0.4

e6/l

20.48

7729

36767

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1002

2066

3.59

265.63

1.6

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1798

5237

2.58

264.66

1.6

178.9

293.0

titre

1.37

246

(3018095) Leukocytes [#/volume] in Urine

11213

60231

1.58

262.50

5.2

3.8

138.7

112.2

e6/l

1.38

8910

43387

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2175

7054

2.33

254.12

2.5

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

18040

108434

1.58

253.69

6.6

4.7

1147.0

1545.8

e6/l

0.59

339

1662

(3035880) pH of Pleural fluid

587

817

5.27

252.48

1.4

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1154

2709

3.16

250.61

1.5

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4249

17811

1.85

249.60

2.8

10.0

9.7

umol/l

0.34

3744

15571

(36304419) Bacteria [Presence] in Urine

9038

46693

1.59

245.32

4.4

3.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1427

3834

2.77

245.07

3.0

2.0

124.7

129.7

g/l

8.35

1093

2721

(3020682) Albumin/Creatinine [Ratio] in Urine

10673

57322

1.56

244.70

4.8

4.0

23.2

7.2

mg/mmol

67.77

7635

35572

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1397

3724

2.79

243.40

1.6

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1388

3690

2.80

243.03

2.0

1.8

12.9

11.3

mg/l

3.21

1286

3385

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4196

17663

1.84

242.57

5.5

3.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3207

12357

1.98

241.69

2.0

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1429

3876

2.75

241.03

4.2

3.1

2.2

1.5

mg/l

103.63

1294

3501

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1040

2356

3.27

238.96

1.5

1.4

—

(3012516) Albumin [Mass/volume] in Urine

10174

54283

1.56

238.33

3.9

3.2

407.6

409.1

mg/l

0.01

7477

33895

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1532

4336

2.64

238.11

1.4

1.5

9.6

15.9

iu/ml

1.94

103

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2010

6506

2.32

235.27

2.3

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

8246

42068

1.59

233.38

6.4

3.8

72.5

88.1

307.65

8057

41118

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7907

40167

1.59

226.38

3.4

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3283

13028

1.93

226.24

2.0

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

948

2102

3.33

225.10

1.5

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

10227

55295

1.53

220.74

3.8

3.2

6.6

7.5

mmol/l

91.89

8480

45542

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1861

6001

2.32

219.22

1.9

1.8

35.2

39.3

u/l

10.18

1447

5234

(40758558) Short blood count panel - Blood

7763

39715

1.57

212.88

8.0

7.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2324

8334

2.10

211.25

1.9

2.0

1.2

1.4

g/l

3.39

2136

7458

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

12884

73580

1.49

210.97

2.5

2.0

90.2

94.4

pmol/l

19.79

7491

37828

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2124

7424

2.15

205.93

7.0

4.6

1.8

1.6

11.18

2008

6979

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

20185

126837

1.55

205.57

11.1

7.5

87.8

79.5

u/l

84.48

19386

118442

(3037756) Immunofixation for Serum or Plasma

1349

3862

2.59

204.36

1.5

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

641

1158

4.06

203.27

1.5

1.4

14.5

12.3

u/l

9.22

613

1112

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

803

1716

3.44

201.51

1.7

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2020

7020

2.16

198.43

2.1

2.3

3.9

3.8

g/l

0.51

1473

4878

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2024

7046

2.15

197.95

2.1

2.3

7.7

7.4

g/l

4.98

1514

5102

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2021

7040

2.15

197.32

2.1

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2072

7319

2.12

195.21

7.2

4.7

0.9

2.56

1959

6874

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3179

13067

1.85

194.81

2.2

2.4

375.6

378.4

nmol/l

0.24

2907

11957

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1908

6578

2.17

190.95

2.0

2.4

10.3

10.2

g/l

0.30

1630

5350

(3005719) IgG [Mass/volume] in Serum or Plasma

2739

10797

1.92

190.52

2.7

2.8

10.8

10.6

g/l

1.05

2536

9816

(3047181) Lactate [Moles/volume] in Blood

1620

5230

2.31

189.57

8.4

5.7

1.4

1.3

mmol/l

5.62

1459

4600

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

910

2188

3.06

189.40

1.5

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3530

15109

1.78

189.23

2.0

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1379

4148

2.47

188.48

3.8

2.1

85.8

88.9

4.86

1331

3871

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1289

3770

2.54

186.73

3.9

2.2

224.7

199.5

16.82

1236

3564

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1132

3105

2.70

186.16

1.2

1.3

81.8

161.5

titre

0.95

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13053

75891

1.46

185.91

5.7

4.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2081

7620

2.05

177.79

3.4

3.2

4.1

4.4

pmol/l

26.06

1876

6643

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1869

6589

2.12

176.37

2.1

2.4

3.3

3.0

g/l

18.89

1490

4977

(3042733) HLA Ab [Presence] in Serum

323

357

6.58

173.36

5.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1074

2974

2.67

173.27

7.7

5.1

1575.9

1147.7

iu/ml

0.21

219

454

(3026250) Tacrolimus [Mass/volume] in Blood

384

511

5.48

172.91

36.8

33.1

7.3

7.2

ug/l

0.37

348

453

(3036489) Thrombin time

1608

5381

2.22

172.57

3.3

1.9

22.9

21.7

5.06

1501

4781

(3019230) Fractional oxyhemoglobin in Venous blood

1019

2755

2.73

172.06

4.6

2.6

64.4

64.0

0.21

1013

2742

(3037522) Nuclear Ab [Titer] in Serum

3971

18079

1.68

169.37

1.4

1.3

496.7

529.2

titre

0.53

935

3854

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1107

3170

2.58

167.10

1.3

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

612

1237

3.62

166.47

1.7

1.4

—

(44806118)

713

1607

3.25

164.68

1.6

1.5

—

(44790049)

713

1608

3.25

164.52

1.6

1.5

—

(44790047)

713

1608

3.25

164.52

1.6

1.5

—

(44790048)

713

1608

3.25

164.52

1.6

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

397

577

5.01

162.94

12.9

1.4

669.5

1235.1

mg/l

0.28

311

392

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1116

3268

2.52

160.91

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1253

3888

2.38

159.70

1.7

1.5

0.2

g/l

0.08

1196

3656

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1694

5986

2.11

158.40

2.2

2.6

0.8

1.1

g/l

3.53

1455

4989

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1513

5143

2.18

155.94

2.0

2.4

0.0

g/l

0.20

1377

4640

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1272

4020

2.34

155.58

1.7

1.5

1.1

1.2

g/l

4.13

1216

3801

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

371

538

5.02

152.65

1.5

1.3

67.0

61.5

1.83

289

444

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1419

4808

2.19

147.23

2.0

2.4

0.0

g/l

0.57

1286

4326

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

939

2640

2.62

146.80

1.2

1.4

40.4

38.2

u/l

0.19

832

2252

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1396

4720

2.19

145.57

2.0

2.5

0.0

g/l

0.00

1283

4309

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

845

2281

2.72

142.87

3.5

2.6

2268.1

5372.6

u/ml

0.38

152

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1546

5483

2.09

142.82

1.9

2.3

35.1

37.7

g/l

45.50

1354

4563

(3017817) Protein [Mass] in Urine collected for unspecified duration

633

1477

3.14

138.21

2.1

2.4

0.4

0.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

17760

112211

1.40

137.29

6.3

4.5

—

(3021589) Normoblasts [#/volume] in Blood

11764

69473

1.38

136.88

16.7

9.7

0.0

e9/l

1.69

9748

56761

(3015377) Calcium [Moles/volume] in Serum or Plasma

9998

57712

1.39

131.85

3.7

3.4

2.3

2.4

mmol/l

53.48

8570

49147

(21494890) Protein electrophoresis panel - 24 hour Urine

718

1856

2.83

131.45

1.7

2.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

887

2565

2.54

130.94

1.8

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

149

13.16

128.80

2.5

2.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

322

486

4.82

126.80

1.4

1.3

2.8

3.9

mmol/l

6.52

294

445

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3196

14762

1.63

125.85

2.8

2.5

42.0

51.6

u/l

0.60

2713

12604

(3004451) EKG impression Narrative

426

813

3.82

125.51

1.4

1.2

—

(3023419) Bacteria identified in Sputum by Culture

771

2130

2.65

124.60

2.2

2.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

870

2566

2.49

123.25

1.8

1.4

17.6

17.3

u/ml

0.02

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5448

28472

1.47

122.85

3.9

3.0

2.8

2.2

e6/l

3.72

3218

15665

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1987

8092

1.83

122.52

1.5

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

310

467

4.83

122.34

1.5

1.3

2.4

2.8

0.31

247

396

(3037121) Protein [Mass/volume] in Urine

1548

5814

1.97

121.88

3.3

3.0

0.5

0.3

g/l

7.21

824

2441

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

801

2284

2.57

121.59

1.8

1.4

121.2

116.1

u/ml

0.42

170

508

(3010375) cycloSPORINE [Mass/volume] in Blood

351

591

4.32

121.59

29.1

28.7

109.7

114.7

ug/l

0.68

269

513

(3014891) Appearance of Pleural fluid

188

166

8.21

121.07

1.6

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6843

37473

1.42

119.78

1.8

1.7

17440250.7

31642280.5

pmol/l

1.58

5648

29954

(3018572) Chloride [Moles/volume] in Blood

1145

3865

2.18

119.48

9.6

6.4

104.2

105.1

mmol/l

6.25

1052

3476

(3039000) Anion gap in Blood

1145

3865

2.18

119.48

9.6

6.4

11.7

11.1

mmol/l

5.60

1052

3476

(3020876) Protein [Mass/time] in 24 hour Urine

598

1471

2.97

119.46

1.8

1.9

2.2

0.9

g/24h

0.89

(3052851) Hemolysis interference index of Serum or Plasma

1384

5049

2.03

118.08

5.0

3.2

—

(3017569) Oxygen content in Arterial blood

389

727

3.90

117.91

2.2

—

(3013512) EKG study

9096

52384

1.38

117.91

6.9

4.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

382

8493

0.31

117.85

1.6

1.9

—

(3003181) Sodium [Moles/volume] in Urine

990

3169

2.30

117.18

1.4

1.3

57.3

63.5

mmol/l

5.02

774

2549

(40760892) CBC W Ordered Manual Differential panel - Blood

5856

31323

1.44

115.97

5.7

4.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

563

1369

3.00

114.71

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

563

1369

3.00

114.71

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

563

1369

3.00

114.71

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

750

2145

2.56

113.12

1.4

1.2

292.7

279.3

u/ml

0.58

501

1308

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

264

370

5.18

112.73

1.5

1.3

21.2

22.5

0.27

212

317

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

618

1601

2.82

112.64

3.6

2.6

—

(3042631) Mycobacterium sp identified in Specimen

832

2523

2.42

111.05

2.5

2.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5725

30734

1.43

110.30

3.6

2.8

1.3

1.2

e6/l

0.32

3465

17797

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

780

2304

2.48

110.08

1.4

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

188

7.25

109.92

1.7

1.4

116.6

114.6

ug/l

0.06

153

152

(3034770) Mitochondria Ab [Titer] in Serum

1049

3548

2.17

108.80

1.2

927.4

910.7

titre

0.03

110

(3019977) pH of Arterial blood

426

902

3.44

108.24

2.7

2.6

7.4

0.16

161

323

(3006576) Bicarbonate [Moles/volume] in Blood

320

551

4.22

107.86

7.7

5.9

25.2

25.0

mmol/l

0.36

284

493

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

345

630

3.98

107.85

2.2

2.1

88.6

97.7

3.78

340

593

(3040151) Glucose [Moles/volume] in Capillary blood

681

1914

2.60

106.34

9.5

9.2

7.6

7.4

mmol/l

1.04

574

1568

(3017181) Myelocytes/100 leukocytes in Blood

2970

14022

1.59

105.64

4.5

3.9

1.0

0.9

0.47

1120

4129

(21494755) Public health laboratory ask at order entry panel

312

7270

0.30

105.05

1.3

1.4

—

(3024932) HLA-DR beta [Type]

263

393

4.86

104.78

1.0

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3051

14538

1.58

104.25

6.6

3.6

1.2

mmol/l

58.22

2818

12461

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1209

4390

2.03

104.25

2.5

2.4

204.3

99.6

ug/min

6.94

736

2509

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

454

1029

3.22

103.86

1.6

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

1039

3586

2.13

102.37

1.2

142.4

129.0

titre

0.17

104

277

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

806

2504

2.36

101.97

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

786

2415

2.38

101.90

1.3

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

10748

64523

1.33

101.57

2.7

2.2

76.1

79.5

nmol/l

25.39

9528

56159

(3024471) HLA-A [Type]

264

408

4.70

101.27

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

844

2696

2.30

100.26

5.8

3.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

429

961

3.25

99.99

1.3

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

267

423

4.58

99.54

1.5

1.3

18.8

22.1

0.95

232

384

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

950

3263

2.14

94.68

1.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

402

895

3.27

94.62

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

401

898

3.25

93.53

1.6

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2674

12696

1.57

92.07

4.3

3.8

0.8

0.6

1.32

818

2978

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

272

467

4.23

92.06

1.3

34.5

426.8

ug/l

3.71

136

264

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

745

2344

2.33

91.57

2.3

2.2

31.8

32.9

8.14

735

2331

(3044927) Protein electrophoresis panel - Urine

639

1874

2.49

91.49

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

2774

13307

1.56

91.28

4.5

3.9

0.1

2.23

1039

3826

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

486

1242

2.85

90.79

1.8

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

880

3001

2.15

89.26

1.4

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

554

1538

2.63

88.62

1.6

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

355

765

3.37

87.89

2.2

1.9

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

202

283

5.17

86.38

1.3

1.1

1.3

1.8

mmol/l

5.95

120

173

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

443

1108

2.91

85.99

2.3

—

(1761868) Lipid panel - Serum or Plasma

5035

46859

0.72

85.97

3.8

3.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

264

469

4.08

85.61

1.9

1.8

21330.7

6770.1

e6/l

1.26

160

245

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

572

1642

2.54

85.59

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

434

1082

2.92

84.73

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

436

1097

2.89

83.76

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

208

5333

0.28

83.22

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

235

392

4.35

82.46

9.5

7.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

564

1638

2.51

82.40

1.2

55.5

68.5

u/l

1.69

379

1082

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

171

213

5.81

82.35

1.6

1.3

9.9

11.6

0.32

106

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

428

1076

2.90

82.34

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1180

4620

1.88

81.54

1.5

1.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

158

184

6.22

81.06

1.4

1.3

21.0

27.9

1.29

121

143

(3023487) Leukocytes [#/volume] in Peritoneal fluid

281

548

3.72

80.48

2.1

2.0

1289.7

5645.0

e6/l

1.22

213

365

(3035350) Ketones [Presence] in Urine by Test strip

12530

78349

1.28

80.32

5.1

3.8

0.0

estimate

0.80

2769

14241

(3026692) Albumin [Mass/volume] in Peritoneal fluid

225

372

4.38

79.82

1.4

16.9

11.6

g/l

13.32

191

271

(3025159) Blasts/100 leukocytes in Blood

2550

12460

1.52

76.41

4.6

3.9

0.1

0.3

2.48

893

3240

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

154

186

5.99

76.40

1.3

1.2

343.2

234.9

u/l

0.13

146

(3009261) Glucose [Presence] in Urine by Test strip

12633

79425

1.27

75.64

5.2

3.9

0.0

estimate

2.80

2633

14079

(40761535) Cells panel - Urine sediment

2922

14741

1.48

74.97

4.5

3.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

162

213

5.51

74.01

1.3

1.2

1.0

1.3

mmol/l

0.30

146

(3004809) Band form neutrophils/100 leukocytes in Blood

818

2920

2.05

73.63

3.6

3.4

1.5

0.10

639

2238

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2661

13252

1.49

72.63

4.1

2.7

48.3

63.8

ml/min/173m2

95.62

1420

5275

(3021601) Nitrite [Presence] in Urine by Test strip

12459

78465

1.26

72.18

6.8

5.1

0.0

estimate

1.08

2785

14458

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

562

1739

2.36

71.70

3.5

3.6

—

(3033799) Differential panel - Peritoneal fluid

245

472

3.76

71.41

2.3

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

547

1677

2.38

71.23

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

263

536

3.56

70.81

1.8

1.6

—

(3025941) Bacteria identified in Stool by Culture

1697

7720

1.62

69.02

1.4

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

318

746

3.10

68.91

1.2

1.1

3.4

3.5

iu/ml

0.07

(3038071) Oxygen [Partial pressure] in Mixed venous blood

199

336

4.29

68.87

9.4

8.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

139

170

5.92

68.19

1.5

1.3

73.0

69.8

0.42

113

143

(3051651) Icteric interference index of Serum or Plasma

358

922

2.82

66.04

5.5

3.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

20666

157749

0.77

65.59

6.0

5.4

2.2

2.6

mmol/l

307.65

18951

142219

(3002331) Protein [Mass/volume] in Peritoneal fluid

194

336

4.18

65.08

1.5

1.3

30.5

45.8

g/l

0.38

166

247

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

218

413

3.82

65.05

6.2

5.5

68.7

71.7

0.81

186

330

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

327

819

2.90

63.42

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

327

820

2.90

63.29

1.4

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

22678

170807

0.75

62.87

50.7

22.4

126.9

135.2

g/l

307.65

22310

167709

(3026361) Erythrocytes [#/volume] in Blood

22675

170787

0.75

62.86

50.3

22.2

4.2

4.5

e12/l

307.65

22058

164599

(3024731) MCV [Entitic volume]

22675

170783

0.75

62.79

50.1

22.2

92.3

91.5

97.25

22295

167680

(3045716) Anion gap in Serum or Plasma

305

739

3.00

62.65

2.4

2.3

8.9

9.0

mmol/l

0.35

247

532

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

128

157

5.90

62.65

1.3

1.2

7.0

206211.3

nmol/l

0.72

104

129

(3044007) Cell count panel - Peritoneal fluid

220

432

3.69

62.51

2.2

1.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

17844

118094

1.25

62.46

5.5

4.1

20.5

13.1

mm/h

307.65

16553

107569

(3035941) MCH [Entitic mass]

22675

170761

0.75

62.39

50.0

22.1

30.3

30.5

45.84

22291

167668

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5706

33044

1.31

62.32

3.2

2.5

mmol/l

20.20

4860

28840

(3021788) Differential panel - Synovial fluid

811

3065

1.93

62.18

1.5

—

(3010813) Leukocytes [#/volume] in Blood

22684

170801

0.75

62.06

50.3

22.3

7.6

6.8

e9/l

290.39

22066

164663

(3007461) Platelets [#/volume] in Blood

22674

170715

0.75

61.67

50.3

22.3

233.0

242.3

e9/l

70.31

22116

165287

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

346

917

2.74

60.58

1.2

115.4

87.8

u/l

4.04

306

791

(3007164) IgA [Mass/volume] in Serum or Plasma

4504

25332

1.34

60.19

1.7

1.5

3.0

2.6

g/l

22.06

2915

14059

(3042111) Morphology [Interpretation] in Bone marrow Narrative

803

3070

1.91

59.50

1.5

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

8.71

59.41

2.9

3.6

—

(3000494) Fungus identified in Specimen by Culture

3453

18707

1.38

58.63

1.7

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

14524

94341

1.23

58.03

4.2

3.1

78.1

53.7

u/l

90.85

13408

85742

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

20144

153734

0.79

57.99

5.4

4.8

4.0

4.5

mmol/l

307.65

18523

139169

(3011397) Hemoglobin [Presence] in Urine by Test strip

6448

38276

1.28

57.45

4.7

3.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

172

300

4.15

57.25

3.6

1.9

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

333

893

2.71

57.06

1.2

34.4

24.9

u/l

2.18

289

754

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

19939

152253

0.79

56.66

5.4

4.7

1.3

1.4

mmol/l

307.65

18213

136780

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

113

136

6.01

56.34

1.2

1.1

15.8

22.3

u/l

2.16

(3017704) Immunofixation for Urine

354

987

2.60

56.26

1.4

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

328

886

2.69

55.45

3.2

3.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

874

3513

1.82

55.42

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

215

454

3.43

55.06

2.1

1.8

182.2

167.1

1.55

199

420

(3029937) Albumin [Presence] in Urine by Test strip

7170

43316

1.26

54.72

5.8

4.3

0.0

estimate

0.87

2482

13764

(3000492) Spirometry study

2471

12780

1.43

54.65

1.7

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

1009

4251

1.74

54.58

5.3

2.9

1.7

1.6

mmol/l

1.42

977

4171

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

376

1103

2.48

53.91

1.2

192.2

150.9

titre

0.37

198

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

306

811

2.74

53.63

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

306

811

2.74

53.63

1.5

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

375

1102

2.47

53.57

1.2

285.7

113.2

titre

0.77

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17252

114553

1.23

53.49

4.4

3.9

15.5

15.0

pmol/l

100.47

15704

101395

(3025315) Body weight

108

6.56

52.94

5.4

4.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

988

4174

1.73

52.92

1.7

1.6

23756.8

13473.0

e6/l

4.42

704

3022

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

614

2229

2.01

52.79

1.3

1.2

—

(40761536) Microorganisms panel - Urine sediment

2561

13422

1.41

52.50

6.1

4.1

—

(3051611) Lipemic interference index of Serum or Plasma

523

1799

2.12

51.90

5.3

3.2

—

(40762365) Oxygen content in Arterial blood by calculation

155

270

4.15

51.72

2.1

3.6

14.8

14.7

ml/dl

0.17

142

255

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

292

770

2.75

51.68

1.3

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

309

842

2.66

51.40

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

309

842

2.66

51.40

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

309

842

2.66

51.40

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

309

842

2.66

51.40

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

247

596

3.00

51.19

2.5

2.8

—

(3041354) Potassium [Moles/volume] in Venous blood

648

2425

1.95

51.13

3.7

2.1

4.2

4.1

mmol/l

9.41

639

2408

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

512

1758

2.12

51.05

1.4

1.2

4.3

3.8

u/ml

0.42

258

751

(3035285) Chloride [Moles/volume] in Venous blood

647

2425

1.94

50.83

3.7

2.1

105.3

105.6

mmol/l

0.70

638

2407

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

20354

154609

0.80

50.63

5.9

5.1

6.5

6.1

mmol/l

247.83

18319

138153

(3051593) INR in Capillary blood by Coagulation assay

331

947

2.54

50.01

15.3

9.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1305

14208

0.64

49.42

1.3

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

261

665

2.84

49.21

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

108

143

5.46

49.13

1.2

14.8

19.3

g/l

5.68

103

124

(3033705) Calcium.ionized [Moles/volume] in Venous blood

633

2398

1.92

48.21

3.8

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

513

1803

2.07

48.17

1.4

1.2

5.6

4.1

u/ml

0.60

191

599

(3039443) Prostate specific Ag panel - Serum or Plasma

144

3338

0.31

47.64

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

189

405

3.38

47.42

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

182

385

3.42

46.57

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

317

924

2.49

46.13

2.5

2.2

22.3

34.5

umol/l

0.80

(3016750) Collection duration of Urine

343

1040

2.39

45.90

2.3

2.1

500.3

497.9

min

0.14

247

743

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

104

142

5.29

45.87

1.2

110.9

99.1

ug/l

0.29

(3008757) Leukocyte morphology finding [Identifier] in Blood

540

1970

1.99

45.84

4.5

3.7

—

(3004775) Volume in Urine collected for unspecified duration

439

1482

2.15

45.73

2.4

2.2

705.4

678.7

0.56

297

963

(3014271) Vancomycin [Susceptibility]

349

1070

2.37

45.58

3.5

2.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

290

823

2.55

44.60

2.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

556

2070

1.95

44.57

1.1

—

(3047189) Immunofixation for 24 hour Urine

289

823

2.55

44.14

1.5

1.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1878

9600

1.44

43.87

3.7

2.8

0.4

0.3

e6/l

2.28

1844

9436

(3044941) Cell count panel - Synovial fluid

654

2587

1.84

43.66

1.5

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

303

890

2.47

43.43

2.1

1.9

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

9.37

43.35

1.1

5089.9

1632.9

ng/l

1.64

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

617

2403

1.87

43.25

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

935

4124

1.66

42.68

1.8

1.7

—

(3012565) Volume of 24 hour Urine

280

800

2.54

42.50

2.3

2.2

1629.4

1956.4

4.57

236

696

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

8.08

42.26

4.4

3.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

303

905

2.43

41.93

1.5

1.4

16.2

13.4

umol/l

6.84

291

846

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

132

5.20

41.19

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

206

3752

0.39

40.96

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

560

2158

1.89

40.57

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

203

503

2.92

40.31

3.0

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

203

503

2.92

40.31

3.0

2.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

328

1037

2.29

40.04

1.1

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

120

210

4.13

39.92

1.3

1.2

707.7

161.6

ng/l

0.42

143

(3038515) Glucose [Moles/volume] in Venous blood

912

4077

1.63

39.50

5.7

3.0

8.0

7.6

mmol/l

3.36

884

4008

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5010

43003

0.80

39.31

2.9

3.2

0.8

ug/l

0.17

3596

30305

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

916

4116

1.62

38.86

1.6

10.5

4.1

iu/ml

0.46

231

976

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

8.35

38.74

14.5

9.1

185.8

149.9

e6/l

0.29

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

311

975

2.31

38.72

1.6

1.5

7.6

6.3

u/l

0.45

149

462

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

550

2146

1.86

38.37

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11631

75679

1.19

38.27

2.8

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

354

1179

2.18

38.21

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

539

2099

1.87

37.84

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

537

2090

1.87

37.76

1.5

1.4

—

(3044889) 12 lead EKG panel

17096

115035

1.19

37.63

6.9

4.0

—

(3012898) Urea [Moles/volume] in Urine

114

5.32

37.35

1.3

1.4

134.9

167.8

mmol/l

1.50

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

495

1884

1.91

37.26

1.1

1.7

1.5

g/l

10.30

460

1675

(3025468) Yersinia sp identified in Specimen by Organism specific culture

531

2073

1.86

37.00

1.5

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

115

208

4.00

36.71

1.4

1.1

75.6

73.7

0.16

(4010399)

2220

12029

1.36

36.61

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

8.89

36.40

12.7

14.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

530

2079

1.85

36.39

1.5

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

140

4.75

36.19

1.6

1.8

46.2

44.6

umol/l

0.14

140

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

528

2076

1.85

35.99

1.5

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

368

1280

2.09

35.63

1.3

1.1

88.3

96.6

5.94

353

1175

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22225

166023

0.81

35.52

16.8

10.9

26.6

25.8

u/l

1.59

21542

158714

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

542

2161

1.82

35.35

1.5

69.2

58.9

7.82

351

1363

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

921

4244

1.58

35.22

1.3

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

12.12

34.85

9.5

9.3

—

(3034426) Prothrombin time (PT)

161

380

3.06

34.80

1.4

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

382

1360

2.04

34.78

1.6

25.3

25.7

u/ml

0.05

309

(3014765) Yersinia sp identified in Stool by Organism specific culture

925

4286

1.57

34.55

1.3

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

215

598

2.60

34.55

1.5

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5156

43638

0.82

34.43

1.7

1.6

1.5

1.3

mmol/l

17.70

4291

35801

(42529406) Shigella sp [Presence] in Stool by Culture

926

4299

1.57

34.30

1.3

1.2

—

(40768797) Stomach Pathology biopsy report

3856

22707

1.26

34.22

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

231

675

2.48

33.60

1.9

2.0

—

(4268621)

337

1160

2.11

33.55

2.6

2.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

112

214

3.78

33.28

1.4

1.1

80.8

83.5

0.26

(3019225) pH of Specimen

3180

18358

1.28

33.17

7.3

4.1

—

(3052592) Norovirus Ag [Presence] in Stool

142

320

3.21

33.11

1.4

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

22289

166244

0.82

32.98

42.5

17.7

104.6

80.5

umol/l

307.65

22278

166184

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

228

670

2.46

32.79

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

545

2234

1.77

32.47

1.4

1.6

0.8

0.9

g/l

0.37

399

1659

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

105

195

3.89

32.43

4.9

5.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

227

670

2.45

32.35

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

370

1339

2.00

32.25

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

456

1773

1.87

32.23

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

467

1831

1.85

32.16

3.6

3.4

62.7

58.5

2.81

307

1163

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

166

419

2.87

32.02

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

128

276

3.35

31.98

8.0

7.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

436

1683

1.88

31.52

1.3

1.1

102.1

118.4

13.57

406

1485

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9265

59864

1.17

30.92

5.8

4.1

—

(3008295) Osmolality of Serum or Plasma

428

1660

1.87

30.51

1.3

276.0

277.6

mosm/kgh2o

0.55

319

1269

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

123

4.64

30.34

2.7

1.8

66.0

55.4

1.38

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

702

3149

1.62

30.03

2.4

1.5

1.0

0.8

nmol/l

6.48

557

2616

(3016038) Potassium [Moles/volume] in Urine

332

1186

2.03

30.03

1.2

32.5

35.5

mmol/l

1.48

284

1000

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

103

200

3.72

29.98

4.7

5.5

55.3

51.7

ug/min

0.19

167

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

415

1610

1.87

29.58

1.5

20.2

29.3

7.23

280

986

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7380

59824

0.85

29.50

4.0

4.6

22.9

22.0

5.14

3535

31363

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.58

29.49

5.5

6.6

441.9

450.3

umol/l

0.07

(40757373) Influenza virus identified in Isolate

133

310

3.10

29.43

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

519

2171

1.74

28.88

1.4

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1040

5141

1.48

28.77

1.2

1.4

0.9

u/ml

0.62

102

473

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

189

541

2.53

28.77

1.8

1.7

20142.2

40698.0

u/ml

0.36

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

313

1113

2.04

28.69

1.3

132.9

62.4

titre

0.60

100

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

362

1357

1.93

28.62

1.9

1.8

5.7

3.9

mg/l

6.48

339

1290

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2485

14151

1.29

28.61

1.8

1.7

1.6

16.42

2023

11991

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

182

517

2.55

28.15

3.3

1.8

61.7

429.5

ug/l

1.05

172

486

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

319

1152

2.01

28.04

1.3

622.8

366.2

titre

0.55

105

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

642

2867

1.63

27.99

1.2

4.1

5.6

u/ml

0.34

233

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

249

821

2.20

27.70

1.2

1.1

35.1

28.3

u/l

0.71

185

605

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

438

1769

1.80

27.49

1.3

1.1

—

(4306422)

434

1748

1.80

27.49

1.3

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

651

2932

1.61

27.43

1.2

6.2

12.4

u/ml

—

(3005322) IgE [Units/volume] in Serum or Plasma

1425

7552

1.38

26.81

1.3

310.7

271.0

u/ml

0.60

1320

6893

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

586

6670

0.62

26.79

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

352

1338

1.91

26.74

1.7

1.4

25.1

25.0

iu/ml

0.01

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

105

225

3.37

26.57

2.3

2.7

141.0

52.4

mg/l

1.14

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

246

822

2.17

26.52

1.2

1.1

104.0

87.8

u/l

1.04

188

633

(3009871) Measles virus Ab [Titer] in Serum

133

331

2.90

26.40

1.3

1.7

—

(3003129) Base excess in Capillary blood by calculation

164

470

2.52

24.98

2.2

1.6

1.0

0.3

mmol/l

1.19

154

443

(40768800) Prostate Pathology biopsy report

426

5144

0.59

24.92

1.1

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

357

1396

1.85

24.91

1.4

2.6

3.0

g/l

3.01

245

948

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

9.35

24.88

9.2

9.1

41.7

47.5

0.37

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3334

19959

1.23

24.85

3.1

4.2

18.0

25.7

ug/l

1.00

2818

16573

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

19809

148478

0.86

24.82

33.6

14.3

64.6

75.9

ml/min/173m2

307.65

17580

122453

(3024139) IgG subclass 3 [Mass/volume] in Serum

356

1395

1.85

24.69

1.4

0.5

0.4

g/l

0.83

244

949

(3010144) Erythrocytes [#/volume] in Synovial fluid

406

1657

1.78

24.67

1.5

1.3

183455.8

139840.1

e6/l

0.50

285

1141

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

269

958

2.03

24.64

1.0

308.5

284.3

mg/l

5.39

247

842

(3027135) IgG subclass 1 [Mass/volume] in Serum

356

1397

1.85

24.58

1.4

7.4

6.9

g/l

1.24

239

952

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.71

24.32

2.6

1.7

13.0

19.5

0.70

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

188

582

2.34

24.30

1.5

1.7

74.1

105.4

umol/l

1.55

105

313

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1426

13546

0.75

24.17

2.1

10.6

12.5

nmol/l

14.32

1180

11792

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

711

3369

1.53

24.13

1.2

1.3

6.3

5.5

u/ml

0.09

368

(3029634) Reagin Ab [Titer] in Serum by VDRL

398

1626

1.77

24.11

2.1

7.6

7.0

titre

0.03

(4062490)

354

1397

1.84

24.02

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

166

488

2.46

24.01

1.3

1.2

0.3

0.9

g/l

1.07

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

195

617

2.29

23.99

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

273

988

2.00

23.94

2.9

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

717

3411

1.53

23.89

1.2

1.3

7.2

6.0

u/ml

0.33

132

542

(21494434) Karyotype in Bone marrow

397

1629

1.77

23.71

1.1

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

5.49

23.55

1.2

1.3

0.1

g/l

1.74

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

252

895

2.04

23.28

2.1

2.2

80.5

127.4

ug/min

0.71

201

(3045142) Bone marrow Pathology biopsy report

475

2060

1.67

23.28

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

136

369

2.66

23.12

2.1

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

19630

147021

0.87

23.04

4.9

4.2

1.4

1.3

mmol/l

59.53

17843

130719

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

150

430

2.52

22.88

1.4

17.1

15.4

pmol/l

1.65

123

351

(3008116) Ketones [Moles/volume] in Urine by Test strip

117

299

2.83

22.24

1.4

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

748

3653

1.49

22.03

1.2

30.3

39.4

u/ml

0.46

207

(3000012) Reticulocyte production index

281

1060

1.92

21.94

1.7

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

436

1882

1.68

21.78

1.6

1.5

—

(3011412) CD3 cells [#/volume] in Blood

342

1387

1.79

21.30

2.2

2.3

0.9

1.1

e9/l

5.34

212

840

(3013727) Leukocytes other/100 leukocytes in Blood

175

559

2.26

21.13

4.1

3.5

59.0

52.6

3.18

170

540

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

292

1130

1.87

21.13

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

6287

40363

1.16

20.84

5.1

3.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

120

325

2.67

20.53

1.2

1.1

74.5

87.3

3.39

154

(3003338) MCHC [Mass/volume]

16561

125122

0.88

20.52

45.9

19.9

327.5

332.5

g/l

307.65

16321

124113

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22336

156027

1.17

20.44

36.0

14.7

27.6

26.6

mg/l

5.42

20975

125124

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

558

2610

1.55

20.14

1.6

1.9

21.1

24.6

ug/l

1.14

534

2563

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

207

3.10

19.93

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

156

487

2.32

19.89

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

546

2553

1.55

19.75

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

418

1834

1.65

19.68

1.2

164.0

202.0

miu/ml

0.77

609

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

197

2763

0.51

19.59

1.4

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

134

3.66

19.55

1.1

11.5

20.4

iu/ml

0.66

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

344

1435

1.74

19.50

1.2

1.3

1.7

1.4

nmol/l

3.77

305

1308

(3020191) Ethanol [Moles/volume] in Serum or Plasma

281

1103

1.84

19.50

1.6

1.3

1.0

1.3

promille

2.81

215

846

(3000570) Elastase.pancreatic [Mass/mass] in Stool

985

5183

1.38

19.37

1.4

258.7

259.2

ug/g

0.02

628

3106

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

106

279

2.74

19.17

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.74

19.06

1.2

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

118

330

2.58

19.01

1.3

1.1

90.3

104.1

2.51

113

304

(3019150) Specific gravity of Urine by Refractometry

5463

34911

1.16

18.99

5.8

4.3

1.0

kg/l

1.19

915

5356

(3011985) Renin [Units/volume] in Plasma

464

2114

1.59

18.79

1.4

87.1

60.6

mu/l

1.51

395

1871

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

196

3.09

18.74

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

636

3108

1.49

18.74

1.6

1.7

4.3

4.6

iu/l

0.17

193

952

(3039162) Centromere protein B Ab [Units/volume] in Serum

371

1604

1.68

18.50

1.2

58.3

54.3

u/ml

0.10

109

(3002621) Streptococcal DNAse B [Units/volume] in Serum

126

3.67

18.45

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

257

1002

1.86

18.26

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

504

5440

0.66

18.02

1.6

—

(4015189)

156

509

2.21

18.00

2.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

101

270

2.70

17.78

1.1

4.5

10.3

pmol/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1029

5536

1.35

17.63

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1911

16818

0.80

17.35

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

225

866

1.88

16.68

4.0

3.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

350

1533

1.65

16.67

1.2

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

450

2102

1.55

16.44

4.5

4.4

340.7

348.8

umol/l

0.59

382

1766

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

111

326

2.46

16.26

1.2

70.4

87.2

3.50

162

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

108

314

2.48

16.16

1.7

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

224

873

1.86

16.00

1.3

1.4

1.2

nmol/l

1.60

161

664

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.87

15.89

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

415

1919

1.57

15.86

1.3

—

nmol/l

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

119

366

2.35

15.80

2.2

2.5

7.7

mmol/l

0.03

230

(3004616) Nuclear Ab [Presence] in Serum

393

1811

1.57

15.27

1.2

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

493

2389

1.50

15.23

2.9

2.0

24.4

27.8

mg/l

0.65

127

622

(3024263) Appearance of Synovial fluid

222

880

1.82

15.07

1.7

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1081

10006

0.77

15.04

2.3

2.4

34.0

29.3

au/ml

0.16

363

(1175426) CD3 cells/100 lymphocytes in Blood

258

1071

1.74

15.01

1.9

2.0

72.7

69.8

1.76

241

1022

(3028433) Virus identified in Specimen by Culture

150

523

2.07

14.77

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

253

1051

1.74

14.70

1.9

14.6

15.7

0.47

420

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

154

544

2.05

14.65

1.1

397.4

171.5

iu/ml

2.10

149

539

(3010503) CD19 cells [#/volume] in Blood

233

946

1.78

14.64

2.2

2.4

0.5

0.4

e9/l

0.07

220

915

(3006922) Hepatitis E virus Ab [Presence] in Serum

221

884

1.81

14.59

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

326

1455

1.62

14.49

1.1

1.0

2.2

iu/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

230

934

1.78

14.45

2.3

2.4

417.8

563.4

e6/l

2.39

192

787

(3043410) Blood group antigens tested for on Red Blood Cells

132

442

2.16

14.42

1.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

968

9031

0.76

14.30

1.2

1.3

37.2

56.4

au/ml

2.23

394

(3034891) Synovial lining cells/100 cells in Synovial fluid

204

801

1.84

14.30

1.5

3.1

4.1

0.51

169

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1676

9874

1.24

14.26

2.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

228

929

1.77

14.17

1.8

2.0

2.8

2.6

u/field

0.13

164

633

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

430

2059

1.51

14.10

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9714

74745

0.90

13.96

4.6

5.4

3.6

3.7

ug/l

0.17

8406

66748

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

7.93

13.96

5.7

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1761

15292

0.82

13.94

1.5

1.6

—

(3036603) Volume of Urine

261

1112

1.70

13.89

1.5

1.6

1773.1

1963.2

0.97

293

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

3.68

13.75

1.2

1.3

113.8

1196.7

u/l

0.79

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

473

4900

0.69

13.72

1.5

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

464

2271

1.48

13.70

2.2

2.6

248.7

1448.7

u/ml

1.56

449

2237

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1179

0.38

13.68

1.3

1.4

58.9

94.0

pmol/l

0.69

385

(21494815) CD4 cells/100 lymphocytes in Specimen

284

1243

1.65

13.67

1.7

2.1

40.0

38.3

0.23

143

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

252

1069

1.70

13.63

1.3

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

457

2235

1.48

13.55

1.3

3.1

1.4

nmol/l

0.31

428

2136

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

457

2241

1.48

13.38

1.3

0.2

0.3

nmol/l

2.12

176

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

348

1611

1.56

13.33

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

217

892

1.76

13.14

2.4

2.5

0.2

0.3

e9/l

4.09

193

783

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

321

1472

1.58

12.83

2.0

2.1

2.5

u/field

0.62

139

559

(3048879) Bone marrow aspiration report

154

575

1.93

12.64

1.5

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

246

1061

1.68

12.57

2.1

2.5

511.4

720.3

e6/l

1.08

101

430

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

109

359

2.19

12.47

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

202

827

1.77

12.43

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

123

426

2.08

12.41

1.6

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

408

1989

1.48

12.34

1.2

1.3

307.4

281.6

pmol/l

0.47

302

1513

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

202

829

1.76

12.33

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

202

2.61

12.18

2.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

159

608

1.89

12.18

2.2

1.9

77.8

55.2

ug/l

1.37

153

595

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

138

506

1.97

11.96

1.2

1.1

2.5

13.7

u/ml

1.35

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

200

2.60

11.94

2.1

—

(40768804) Tissue Pathology biopsy report

8426

64946

0.91

11.93

2.3

2.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

4.70

11.89

4.8

4.4

21.0

16.7

0.42

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.65

11.89

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

259

1153

1.62

11.74

1.2

5.6

3.1

u/ml

—

(3008536) Aspergillus sp Ab [Presence] in Serum

322

2.22

11.70

1.8

2.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

4.60

11.62

5.9

6.2

0.9

1.1

mg/l

0.65

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

175

2.68

11.46

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

269

1220

1.59

11.33

1.2

38.9

40.5

u/ml

0.04

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

117

3.08

11.27

1.4

1.3

0.5

1.1

ml/s/173m2

3.74

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

268

1216

1.59

11.27

1.2

65.3

86.0

u/ml

0.44

(3049717) Cytology report of Urine Cyto stain

1411

8371

1.23

11.26

2.6

2.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

248

2.36

11.02

1.3

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

416

4231

0.70

10.96

1.6

1.7

44.1

44.2

nmol/l

0.04

396

4058

(37019676) Renin [Units/volume] in Plasma --supine

5.15

10.93

1.0

1.2

49.4

58.0

mu/l

0.07

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

292

2.22

10.74

2.2

3.0

—

(3038026) Centromere Ab [Units/volume] in Serum

272

1255

1.57

10.68

1.2

5.8

54.6

u/ml

4.82

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

483

2503

1.40

10.60

1.2

58.0

47.0

u/ml

0.62

255

(4281824)

320

1540

1.50

10.39

1.3

1.1

—

(3022621) pH of Urine by Test strip

1792

10974

1.19

10.26

3.8

3.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.99

10.16

1.0

1.1

167.0

224.1

pmol/l

0.37

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

182

770

1.71

10.09

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.92

9.93

1.1

1.0

5.7

5.6

mmol/l

0.05

(40761511) CBC panel - Blood by Automated count

21771

160066

0.90

9.93

33.6

14.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

198

862

1.66

9.88

1.3

1.2

223.2

370.2

u/l

1.28

186

793

(3019832) Treponema pallidum Ab [Presence] in Serum

835

4741

1.28

9.86

1.7

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

146

589

1.79

9.56

1.2

39.5

40.0

g/l

0.15

315

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

194

848

1.65

9.55

2.4

2.8

36.3

36.9

0.10

283

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.79

9.51

2.4

2.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

152

622

1.76

9.50

1.6

1.7

12.3

15.1

umol/l

0.45

117

428

(1002224) Polysomnography panel

469

4566

0.74

9.48

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

123

472

1.88

9.44

2.1

22.2

46.6

u/l

2.29

110

435

(3001686) Cold agglutinin [Titer] in Serum or Plasma

300

2.12

9.37

1.3

154.1

216.0

titre

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

289

1395

1.50

9.31

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

191

2.42

9.27

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

161

676

1.72

9.22

3.7

2.3

—

(3002619) Bacteria identified in Specimen by Culture

322

2.06

9.17

1.5

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

242

2.24

9.14

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

120

464

1.87

9.03

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

126

2.75

8.96

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.36

8.83

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.06

8.76

6.1

5.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4386

28885

1.11

8.68

1.3

1.2

1.9

u/ml

0.04

1076

7049

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

129

520

1.79

8.53

1.7

2.0

—

(3000330) Specific gravity of Urine by Test strip

1510

9267

1.18

8.46

4.9

3.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3640

23761

1.12

8.44

1.3

45.2

38.9

iu/ml

1.13

1158

7209

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

208

956

1.57

8.42

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

20100

141424

1.09

8.38

5.6

4.7

2.2

2.1

mu/l

0.05

18469

126114

(3016228) CD19 cells/100 cells in Blood

148

626

1.71

8.31

1.8

2.0

7.3

8.8

0.74

142

608

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

5.41

8.28

1.1

1.0

31.5

21.1

iu/ml

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

207

955

1.57

8.26

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

207

956

1.56

8.22

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

206

951

1.56

8.20

1.1

—

(4094501)

487

4609

0.76

8.15

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

142

2.54

8.07

1.3

1.8

0.7

1.2

mmol/l

0.73

(3046861) Legionella sp Ag [Presence] in Urine

2.90

8.04

1.1

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

205

950

1.56

8.04

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

205

952

1.56

7.97

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.89

7.91

3.6

2.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

483

0.28

7.91

1.3

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

102

2.83

7.91

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

143

608

1.70

7.90

1.7

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

166

735

1.63

7.87

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

131

545

1.74

7.83

1.4

1.3

71.9

56.5

6.53

116

462

(21494567) Legionella sp IgM Ab [Presence] in Serum

104

2.77

7.65

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

173

1935

0.64

7.62

2.0

1.9

—

(3006270) Folate [Moles/volume] in Blood

294

1485

1.43

7.61

1.3

1.2

300.4

335.9

nmol/l

1.78

238

1165

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

131

1560

0.60

7.59

2.0

1.9

—

(3037556) Urate [Mass/volume] in Serum or Plasma

127

529

1.73

7.57

1.8

1.4

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.32

7.44

1.3

1.4

147.5

122.9

ug/l

0.22

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.32

7.44

1.0

1.1

1.4

u/field

0.17

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

102

2.76

7.39

1.1

1.2

1.1

u/field

0.60

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.56

7.35

3.6

2.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

312

3098

0.72

7.28

1.9

179.5

197.0

pmol/l

2.17

291

2875

(3023103) Potassium [Moles/volume] in Serum or Plasma

22644

165682

0.91

7.27

46.3

17.4

4.1

4.0

mmol/l

233.96

22210

161081

(3019174) dRVVT (LA screen)

2.77

7.26

1.2

—

(3017732) Neutrophils [#/volume] in Blood

1692

10634

1.16

7.06

3.6

3.1

4.8

4.1

e9/l

14.87

1175

7668

(3026389) Candida sp identified in Specimen by Organism specific culture

398

2144

1.34

7.04

1.4

—

(4146454)

407

2200

1.34

7.04

2.9

2.7

—

(4034850)

875

5198

1.22

7.03

20.5

10.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

139

609

1.65

6.93

1.8

1.6

5.1

8.8

nmol/l

0.44

119

522

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

5.41

6.91

1.0

1.4

—

(3008898) HLA-B27 [Presence]

330

3217

0.74

6.86

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

6.25

6.82

1.2

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

275

1.97

6.71

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.00

6.65

3.9

3.7

—

(3045414) Leukocytes [Presence] in Urine

1189

7308

1.18

6.62

2.4

1.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

149

673

1.60

6.60

1.1

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

110

459

1.73

6.58

2.1

2.0

12.5

12.1

0.07

416

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1120

6854

1.18

6.56

2.4

3.5

706.9

1785.7

u/ml

1.40

933

5896

(1761482) Bacteria [#/volume] in Urine by Culture

875

5236

1.21

6.56

5.6

4.3

—

(3020491) Glucose [Moles/volume] in Blood

232

1156

1.45

6.53

2.2

1.9

8.1

7.1

mmol/l

3.25

164

776

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

314

1.88

6.49

1.1

1.2

—

(4035726)

2398

15517

1.12

6.44

1.6

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

409

3829

0.77

6.41

3.5

1.6

6.6

3.6

mg/l

3.54

376

2743

(3013139) Helicobacter pylori Ag [Presence] in Stool

1206

10096

0.85

6.35

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

110

465

1.71

6.31

2.0

1.9

32.0

29.0

0.99

434

(3016244) Insulin [Units/volume] in Serum or Plasma

122

531

1.66

6.29

3.1

2.7

33.4

21.2

mu/l

1.43

107

494

(3020717) Zinc [Moles/volume] in Serum or Plasma

129

570

1.63

6.27

1.4

1.5

16.0

25.3

umol/l

3.90

122

542

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

107

453

1.70

6.12

2.8

2.9

—

(3020393) Adenovirus Ag [Presence] in Stool

172

2.18

6.12

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

149

2.27

6.10

2.2

2.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

22637

165366

0.92

5.92

46.0

17.2

139.1

139.6

mmol/l

145.39

22221

161016

(3001186) Copper [Moles/volume] in Serum or Plasma

283

1.89

5.92

1.1

17.7

16.1

umol/l

2.02

254

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

115

1325

0.62

5.91

1.0

255.4

337.2

ng/l

5.05

888

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

377

1.76

5.91

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

386

2128

1.31

5.90

1.7

1.5

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.73

5.82

1.0

1.2

44.5

39.6

mg/l

—

(3044009) aPTT.lupus sensitive (LA screen)

2.55

5.80

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

117

1334

0.63

5.75

1.0

36.6

43.4

ng/l

1.74

878

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.65

5.72

1.1

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.69

5.70

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

117

1330

0.63

5.68

1.0

742.2

703.5

ng/l

0.44

856

(3050129) First trimester maternal screen panel - Serum or Plasma

369

0.31

5.68

1.6

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

138

637

1.56

5.65

2.1

2.3

64.5

56.1

umol/l

1.74

510

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

218

1.98

5.58

2.2

2.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

291

1.83

5.47

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

287

1.83

5.40

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

745

6391

0.84

5.32

1.1

—

(3018133) Calcium [Moles/volume] in Urine

190

2.01

5.14

1.5

1.7

2.1

2.6

mmol/l

0.79

166

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

226

1.91

5.08

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

325

1.75

5.07

1.4

1.2

1.0

48.3

mg/l

1.25

255

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

105

467

1.62

5.07

1.4

3840428.6

1282690.9

iu/ml

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

135

2.19

4.95

2.1

1.2

24.3

20.9

mmol/l

3.06

102

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

404

1.66

4.93

2.2

2.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

835

5131

1.18

4.77

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

190

974

1.41

4.72

1.7

2.0

636.3

1668.7

u/l

0.97

323

(3029075) Extractable nuclear Ab panel - Serum

366

1.68

4.68

1.1

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

300

1660

1.31

4.58

3.3

3.0

89.6

38.7

mg/l

2.34

225

1202

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

138

671

1.48

4.55

1.1

ratio

1.61

213

(3014051) Protein [Presence] in Urine by Test strip

624

3760

1.20

4.49

2.9

2.2

—

(4198724)

285

1.75

4.42

1.4

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

331

0.37

4.36

1.4

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

175

899

1.40

4.34

1.2

1.3

0.9

1.6

u/ml

0.80

110

480

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

313

0.37

4.16

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

312

0.37

4.14

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

233

1264

1.33

4.13

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

311

0.37

4.11

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

311

0.37

4.11

1.4

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.20

3.99

1.3

0.8

0.6

u/field

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.55

3.90

10.3

8.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

414

1.57

3.88

1.2

357.2

268.9

pmol/l

0.51

297

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

414

1.57

3.88

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

165

1.92

3.86

1.1

1.0

—

(3045424) Erythrocytes [Presence] in Urine

469

2797

1.21

3.83

1.6

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.99

3.81

1.0

1.2

—

mmol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

377

2202

1.24

3.77

1.1

70.9

533.7

iu/ml

0.85

430

(3043238) Trisomy 21 risk [Likelihood] in Fetus

266

0.35

3.76

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

18494

135449

0.95

3.75

36.8

16.5

36.9

39.2

114.31

10676

86658

(40768443) Skin Pathology biopsy report

1185

7611

1.13

3.72

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

275

0.37

3.72

1.6

1.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.67

3.71

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

351

1.60

3.71

1.1

—

(3025130) Human papilloma virus identified in Specimen

969

0.66

3.70

2.0

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

184

1.84

3.65

4.2

2.8

1.5

1.1

mg/l

0.87

134

(4024509)

299

1711

1.26

3.60

1.7

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

259

0.36

3.57

1.5

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

608

3738

1.18

3.56

5.3

3.4

30.2

28.9

mg/l

0.35

453

2339

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

292

1669

1.26

3.56

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.60

3.54

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

390

1.55

3.52

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

390

1.55

3.52

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

390

1.55

3.52

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

390

1.55

3.52

1.1

—

(3005033) Fetal Nuchal fold Thickness US

257

0.36

3.52

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

120

1222

0.71

3.51

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

219

1.74

3.48

3.2

3.1

39.0

41.2

umol/l

0.29

186

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

258

1.68

3.43

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

132

1.97

3.40

1.4

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

544

0.57

3.40

1.2

—

(40765096) Chromosome analysis panel by Banding

108

534

1.46

3.39

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

6.41

3.37

1.1

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

965

0.68

3.35

1.1

1.0

3.1

3.3

u/ml

0.02

390

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

222

1.72

3.33

2.4

2.9

0.5

u/field

0.01

222

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

193

1813

0.77

3.33

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

662

4125

1.16

3.30

2.6

3.3

1602.7

661.0

u/ml

0.47

586

3745

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

718

0.63

3.29

1.1

1.4

1.6

1.5

g/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2900

22276

0.93

3.24

5.2

4.9

32.8

32.7

0.17

2200

14370

(3000060) B lymphocytes [#/volume] in Blood

313

1.59

3.22

1.9

2.0

1057.8

1905.1

e6/l

0.30

166

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

164

882

1.34

3.19

1.8

1.5

7.7

5.9

u/l

0.64

137

729

(40768793) Breast Pathology biopsy report

339

2968

0.82

3.18

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

360

1.54

3.17

1.2

137.2

56.5

mu/l

2.00

261

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.49

3.12

1.1

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.45

3.06

1.1

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.61

3.05

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

117

1164

0.72

3.03

1.1

1.0

1.7

2.0

u/ml

0.13

274

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

120

1189

0.73

3.03

5.0

5.2

77.7

93.4

u/ml

0.14

341

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.63

3.01

1.1

1.4

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.55

2.94

1.6

1.1

34.2

10.7

u/ml

—

(44806420)

116

602

1.39

2.86

2.2

2.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

105

536

1.41

2.84

11.6

17.1

1387.4

1405.9

nmol/l

0.08

100

514

(1617658) Protocol used for examination of sentinel lymph nodes

102

1025

0.72

2.84

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

173

1604

0.78

2.77

1.2

8.7

7.7

mmol/l

3.24

129

1110

(3039744) RNA polymerase III Ab [Units/volume] in Serum

112

1.93

2.75

1.1

1.0

9.6

3.7

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

202

1155

1.26

2.57

3.3

2.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

779

0.69

2.56

1.0

0.0

0.5

u/ml

1.30

221

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

481

1.41

2.55

1.1

1646.4

1604.0

miu/ml

0.14

481

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

248

1455

1.23

2.52

1.8

4125.7

2031.0

titre

—

(3006462) Nitrate [Presence] in Urine

148

816

1.31

2.51

4.3

3.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

270

1600

1.22

2.50

1.2

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

891

0.72

2.47

1.1

1.0

3.7

3.5

u/ml

0.04

356

(4211845)

159

888

1.29

2.46

4.1

3.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

129

0.33

2.46

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

123

1.82

2.41

1.2

1.1

9.7

12.1

u/l

0.31

123

(3013466) aPTT in Blood by Coagulation assay

2.24

2.41

1.1

37.8

39.5

0.31

(3035082) Kappa light chains [Mass/volume] in Urine

2.35

2.39

1.0

1.1

0.1

0.3

g/l

—

(3030313) Adrenal Ab [Titer] in Serum

2.17

2.39

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

190

1090

1.26

2.38

1.2

12.3

12.0

mmol/l

0.22

362

(3033923) Metanephrine [Moles/time] in 24 hour Urine

350

1.46

2.37

1.1

0.7

umol/24h

0.16

160

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

125

1.79

2.31

1.2

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

246

2142

0.83

2.30

1.5

1.4

25.4

32.0

iu/l

2.63

202

1793

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3256

22319

1.06

2.29

1.3

1.2

17.1

14.3

u/ml

0.48

1050

7774

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

259

1546

1.21

2.26

1.4

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

161

1463

0.79

2.26

1.1

—

28.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

178

0.40

2.25

1.1

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

452

1.39

2.21

1.5

1.3

27.6

35.4

1.13

298

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.62

2.21

1.0

1.5

—

1932.8

umol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

255

0.51

2.21

2.0

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

112

1.80

2.15

1.1

—

(40768441) Liver Pathology biopsy report

193

1129

1.23

2.09

1.4

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

860

5628

1.10

2.09

1.1

207.9

214.2

titre

0.02

135

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

688

0.71

2.07

1.3

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

107

0.34

2.06

8.8

5.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

108

0.33

2.05

4.4

2.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

190

0.45

2.04

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.97

2.02

1.8

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

176

1.60

1.98

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

176

1.60

1.98

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

176

1.60

1.98

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

421

1.37

1.93

1.6

0.4

ug/l

0.36

253

(3021374) Sirolimus [Mass/volume] in Blood

3.93

1.91

7.5

9.9

6.8

7.7

ug/l

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

1.91

0.0

1.0

—

164.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

1.91

0.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

241

1457

1.19

1.90

3.4

3.7

77.9

52.4

u/ml

0.72

232

1434

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

116

647

1.29

1.90

1.3

50.3

61.0

0.51

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.40

1.90

1.1

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

106

585

1.31

1.88

2.5

2.9

30.0

28.9

umol/l

0.40

440

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

296

1.44

1.87

3.1

5.0

40.1

55.0

u/l

0.63

103

(3028707) Methadone [Presence] in Urine by Screen method

151

873

1.25

1.86

2.4

2.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

118

1.71

1.85

1.5

1.7

1.0

0.8

0.19

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.48

1.85

1.3

1.0

2.3

2.7

0.26

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

919

0.77

1.84

1.2

1.1

39.0

46.2

mg/l

1.21

778

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

870

0.76

1.84

1.1

262.3

320.1

mg/l

2.44

765

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

126

715

1.27

1.82

1.3

—

(3015183) Erythrocyte sedimentation rate

459

0.67

1.80

1.5

1.2

—

(4212803)

187

1.54

1.79

1.2

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

3.60

1.78

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.90

1.75

1.8

1.6

0.3

u/l

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.80

1.74

1.0

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.80

1.74

1.2

1.5

1.3

1.0

u/field

0.44

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

387

1.36

1.72

2.6

2.5

139.1

143.7

nmol/l

0.15

334

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

1.71

0.0

1.3

—

367.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.28

1.71

1.5

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

512

1.31

1.71

7.3

12.3

770.1

826.8

nmol/l

0.55

480

(3013293) Extractable nuclear Ab [Presence] in Serum

201

1.51

1.70

1.6

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.88

1.69

1.8

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

645

0.74

1.69

1.1

1.2

1.1

u/l

0.61

319

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

833

0.77

1.68

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

891

0.78

1.59

5.7

6.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

151

1319

0.82

1.57

1.0

1.1

0.7

1.2

u/ml

0.65

564

(3002256) Pathology report gross observation

2947

22114

0.96

1.55

1.4

1.3

—

(3028468) Fragments [Presence] in Blood by Light microscopy

3.60

1.55

1.0

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

212

1.46

1.54

1.3

7.5

6.2

mmol/l

0.55

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

122

0.47

1.50

1.1

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

181

1546

0.84

1.49

1.1

2.1

1.4

u/ml

0.21

642

(3000285) Sodium [Moles/volume] in Blood

244

1.42

1.48

1.2

—

(3001729) Color of Synovial fluid

144

1.55

1.47

1.5

1.6

—

(3028300) Cannabinoids [Presence] in Urine

219

1837

0.86

1.45

2.5

2.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

545

0.74

1.44

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.74

1.44

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

169

1.49

1.41

4.1

5.8

—

(3027008) Opiates [Presence] in Urine

219

1831

0.86

1.41

2.5

1.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

112

1.61

1.38

1.1

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.80

1.38

1.6

2.2

1.0

mg/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.80

1.38

1.0

—

(3027944) Amphetamines [Presence] in Urine

213

1781

0.86

1.38

2.6

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

20449

148410

0.97

1.33

8.7

6.4

44.5

40.4

mmol/mol

307.65

18932

134678

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.00

1.33

1.2

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

293

0.66

1.31

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

159

1354

0.85

1.31

1.0

1.1

5.0

3.2

u/ml

0.51

653

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

120

1.56

1.29

1.2

1.0

111.8

83.1

ug/l

0.85

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

484

3169

1.10

1.29

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

703

0.79

1.27

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

441

1.27

1.25

1.3

1.2

34.5

21.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

146

885

1.19

1.23

1.3

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

189

1171

1.16

1.23

1.3

2.3

2.2

mmol/l

0.15

179

1088

(3007463) Buprenorphine [Presence] in Urine

2.77

1.23

1.0

11.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

106

0.48

1.22

1.0

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.75

1.20

1.6

1.7

2.1

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.75

1.20

1.6

3.2

3.0

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.75

1.20

1.6

3.4

0.8

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.75

1.20

1.6

1.2

2.4

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.75

1.20

1.6

0.2

1.4

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.75

1.20

1.6

4.3

2.2

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.75

1.20

1.6

4.1

2.6

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.75

1.20

1.6

0.1

1.2

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.75

1.20

1.6

0.3

1.8

mg/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

255

1.36

1.20

1.3

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

641

0.79

1.20

1.0

1.1

282.9

787.7

ng/l

0.89

169

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.40

1.20

6.5

4.5

—

(3022145) Colonoscopy Study observation

2675

18577

1.04

1.19

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

221

1819

0.87

1.19

2.5

2.0

—

(3003694) ABO and Rh group [Type] in Blood

5741

40404

1.03

1.19

1.4

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

400

1.28

1.19

1.6

11.5

9.4

ug/l

2.40

400

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3278

22858

1.04

1.19

16.0

6.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

496

3269

1.09

1.18

1.1

21.4

9.3

u/ml

0.81

254

(3023436) Glucagon [Mass/volume] in Serum or Plasma

100

1.59

1.18

1.7

1.6

202.5

203.8

ng/l

0.02

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

840

1.18

1.14

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

160

1.44

1.13

1.0

1.2

2.2

1.7

umol/24h

1.79

160

(3019420) Tryptase [Mass/volume] in Serum or Plasma

108

644

1.21

1.11

1.5

1.6

11.5

9.4

ug/l

0.24

587

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.56

1.07

1.3

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.19

1.07

1.1

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

110

0.52

1.05

1.0

1.1

—

(44806071)

157

1.42

1.04

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

418

0.76

1.03

1.0

1.1

0.3

1.3

u/ml

2.64

114

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.69

1.03

1.0

1.1

225.0

275.9

nmol/l

0.72

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

142

876

1.17

1.02

1.3

1.2

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.45

1.02

1.0

13.3

8.1

mu/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.99

0.0

6.1

—

0.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

227

1.33

0.98

1.3

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

492

3276

1.08

0.98

1.3

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

166

1.39

0.96

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.50

0.96

1.0

1.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

247

1.31

0.96

1.8

1.7

62.0

52.2

pmol/l

0.30

198

(3007733) Chloride [Moles/volume] in Urine

1.80

0.95

1.1

95.3

82.9

mmol/l

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.80

0.95

1.0

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

148

1.41

0.95

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.76

0.95

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

641

4317

1.07

0.95

1.6

1.7

—

(3020650) Glucose [Presence] in Urine

363

0.75

0.95

1.6

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

761

0.83

0.94

4.5

5.2

328.4

1439.6

u/ml

0.59

131

(36660697) Celiac disease serology panel - Serum

1547

10686

1.05

0.94

1.2

—

(40768795) Lymph node Pathology biopsy report

261

1691

1.11

0.93

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.70

0.93

1.1

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

192

1.35

0.93

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

149

1.40

0.92

1.3

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.60

0.92

1.3

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.54

0.90

1.3

313.6

338.0

umol/24h

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.61

0.89

1.1

1.2

—

(3049242) von Willebrand panel - Platelet poor plasma

1.76

0.87

1.3

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

257

0.73

0.84

1.8

1.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

443

0.80

0.83

1.0

1.1

0.8

1.4

u/ml

0.54

147

(3016879) Cocaine [Presence] in Urine

214

1715

0.90

0.83

2.5

2.0

—

(4133840)

363

1.23

0.82

1.2

—

(4027681)

640

0.83

0.82

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

396

1.22

0.82

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

1.88

0.80

2.5

2.7

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

105

1.44

0.79

1.1

14.6

14.7

nmol/l

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

221

0.72

0.79

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

320

1.24

0.78

2.5

2.7

2532.1

1320.5

u/l

0.45

285

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

593

4022

1.06

0.76

1.2

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

499

1.18

0.76

1.0

1.1

96.4

97.8

0.13

380

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

427

1.20

0.75

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

316

2469

0.92

0.74

1.7

1.8

465.3

290.3

mu/l

0.82

288

2291

(3022475) Manganese [Moles/volume] in Blood

0.55

0.74

1.0

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

194

1.30

0.74

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.60

0.71

1.1

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

503

1.17

0.71

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

132

0.65

0.70

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

384

1.20

0.70

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

288

2250

0.92

0.69

3.5

3.6

37.1

41.3

u/ml

0.21

270

2187

(3018291) Platelet Ab [Presence] in Serum

1.68

0.68

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

172

1.30

0.66

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

181

1441

0.90

0.66

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1068

7391

1.04

0.66

1.2

105.1

131.8

iu/ml

1.66

338

2547

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

616

0.85

0.65

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

375

1.19

0.64

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

560

0.85

0.64

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.59

0.64

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

861

1.12

0.63

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

253

1.22

0.60

1.3

1.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

2267

15937

1.03

0.58

1.9

2.2

214.4

153.1

ug/g

4.41

1785

12286

(3045683) HLA typing for celiac disease panel - Blood or Tissue

585

0.86

0.58

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

196

1.25

0.57

1.2

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

196

1.25

0.57

1.5

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

303

0.81

0.56

2.8

3.2

8.0

7.4

mg/l

0.19

248

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

422

1.16

0.55

1.2

0.3

g/l

1.67

338

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.51

0.55

1.2

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

423

1.16

0.54

1.0

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

498

3773

0.95

0.53

1.4

1.3

593.6

573.5

mg/l

0.14

480

3568

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.54

0.53

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

196

0.77

0.52

1.1

7.9

9.1

mg/g

0.39

184

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

432

1.15

0.51

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

219

0.79

0.50

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

430

3263

0.95

0.50

1.5

673.3

2137.0

e6/l

1.38

377

2657

(46235168) Fasting glucose [Moles/volume] in Blood

161

1.25

0.49

1.8

2.7

8.7

7.3

mmol/l

1.94

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

414

0.85

0.49

1.0

1.1

—

(3027874) Urate [Moles/volume] in Urine

1.44

0.49

1.1

1.7

mmol/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

428

1.14

0.48

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

430

3258

0.95

0.48

1.4

11.8

34.6

e6/l

2.64

352

2522

(3028679) Herpes simplex virus Ab [Presence] in Serum

551

1.12

0.47

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

248

1.19

0.46

1.0

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.40

0.46

2.1

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

396

1.15

0.46

1.2

113.1

113.7

0.07

346

(3002523) Influenza virus A Ag [Presence] in Specimen

160

1249

0.92

0.45

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.47

0.45

1.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

546

0.88

0.43

15.1

12.5

0.6

mmol/l

0.99

496

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.64

0.43

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

161

1249

0.93

0.40

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.66

0.40

1.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.40

0.0

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.44

0.39

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

118

926

0.92

0.39

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

187

1.19

0.38

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

574

1.10

0.38

1.0

1.1

5.3

4.8

u/ml

0.09

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

444

1.12

0.38

1.2

133.0

133.9

nmol/l

0.01

318

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

202

0.82

0.37

2.0

2.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

186

0.81

0.37

1.2

1.3

9.1

9.7

mmol/l

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.30

0.37

1.6

1.7

1.4

umol/l

0.05

(3005011) Chlamydia sp Ab [Titer] in Serum

175

1.19

0.36

1.5

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

403

3028

0.96

0.36

1.4

—

(3003577) Lead [Moles/volume] in Blood

0.73

0.36

1.1

1.2

—

0.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.28

0.35

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

123

1.23

0.34

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

113

0.76

0.34

1.1

1.0

—

(3017509) Phencyclidine [Presence] in Urine

1.33

0.34

1.7

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.33

0.34

1.2

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

678

0.91

0.33

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

380

1.12

0.33

6.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

337

0.88

0.33

1.0

1.1

0.8

1.9

u/ml

—

(3025577) Chromium [Mass/volume] in Blood

184

1403

0.94

0.31

1.9

2.1

2.3

ug/l

0.35

146

1173

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

281

0.87

0.30

1.1

1.6

3.0

2.2

ug/l

0.37

155

(3004446) Plasmodium sp identified in Blood by Light microscopy

110

0.79

0.29

2.0

2.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

515

1.09

0.29

1.6

2.1

2.0

umol/l

0.32

483

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

254

1.13

0.29

1.0

1.2

—

(40760410) HLA-B [Type] by High resolution

1.25

0.27

1.0

—

(40760409) HLA-A [Type] by High resolution

1.25

0.27

1.0

—

(40763590) HLA-DQ beta [Type]

1.25

0.27

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.25

0.27

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

101

0.78

0.27

2.4

2.6

—

(40758292) HTLV I+II Ab panel - Serum

225

0.86

0.27

1.5

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.23

0.27

1.0

1.2

—

(3013862) HLA-DP [Type]

1.20

0.26

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

311

2157

1.04

0.26

3.6

3.4

16.0

9.2

nmol/l

0.72

301

2102

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

115

883

0.94

0.26

1.3

32.7

30.1

u/l

0.33

711

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.27

0.26

1.6

1.3

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

148

1.17

0.26

1.5

1.1

12.2

29.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

187

1412

0.95

0.24

2.4

2.1

—

(3022689) Creatine [Moles/volume] in Urine

500

1.08

0.24

1.5

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.23

0.24

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

190

1.14

0.24

1.0

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

330

2458

0.97

0.23

1.5

1.4

253.9

210.0

pmol/l

0.55

321

2390

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.74

0.23

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

108

733

1.06

0.22

1.2

1.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

142

973

1.05

0.22

1.6

2.0

15.8

16.1

nmol/l

0.20

132

901

(3011288) Drugs identified in Urine by Screen method

154

1163

0.95

0.21

4.3

2.9

—

(3032641) Amino acids panel - Urine

0.00

0.21

0.0

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

247

1.11

0.21

1.0

1.1

0.3

1.2

u/ml

1.18

122

(3002385) Erythrocyte distribution width [Ratio]

17330

125142

0.99

0.20

41.3

18.5

14.7

13.8

307.65

16971

122284

(3011897) Casein IgE Ab [Units/volume] in Serum

111

1.17

0.20

1.1

1.3

0.0

1.2

u/ml

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

214

1.11

0.19

3.4

3.2

68.6

151.8

ng/l

1.50

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

203

0.89

0.19

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

446

3292

0.98

0.19

1.3

4.3

3.8

mmol/l

8.45

422

3090

(3029396) Erythrocyte agglutination [Presence] in Blood

1.20

0.19

1.5

1.9

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.23

0.18

1.1

1.4

229.3

571.0

nmol/l

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

111

0.84

0.18

1.1

1.5

8.5

14.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.12

0.17

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

108

815

0.95

0.16

1.3

1.4

0.2

nmol/l

0.55

574

(40762814) Titanium [Mass/volume] in Blood

398

1.07

0.16

2.0

2.2

3.5

3.4

ug/l

0.03

140

(44813793)

115

866

0.96

0.16

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

194

1443

0.97

0.15

1.8

2.0

4.3

3.7

ug/l

0.27

161

1273

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

107

1.14

0.15

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

217

1609

0.97

0.15

1.5

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

115

1.13

0.14

1.2

1.1

1.0

0.6

u/ml

0.20

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

115

0.88

0.13

1.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

130

0.89

0.13

1.2

1.5

67.9

37.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

640

0.96

0.13

1.2

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

786

5595

1.01

0.12

1.1

28.8

5.5

u/ml

0.43

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

158

1.09

0.12

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

425

1.05

0.12

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

557

0.96

0.11

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.16

0.10

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

386

0.95

0.10

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

209

1.07

0.09

8.7

9.1

0.4

umol/l

0.11

191

(3035933) Granulocytes/100 leukocytes in Blood

275

0.94

0.09

2.1

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

195

1375

1.02

0.09

1.2

1.1

7.0

3.8

u/ml

0.73

459

(3024869) Neuronal Ab [Presence] in Serum

351

1.05

0.09

1.1

—

(3013762) Body weight Measured

1.08

0.09

1.0

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

288

1.05

0.08

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.10

0.08

1.0

1.4

0.1

1.0

u/ml

—

(3042517) Benzodiazepines panel - Urine

1.09

0.07

1.8

2.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

214

0.94

0.07

1.0

1.1

19.6

9.5

u/ml

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.90

0.07

1.1

1.4

0.4

2.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

102

717

1.02

0.07

1.0

1.1

10.5

10.9

iu/ml

0.06

145

(40758358) Immune stain study

0.86

0.07

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.85

0.07

9.8

8.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

393

2801

1.01

0.06

1.4

12.4

9.9

u/l

2.43

315

2217

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

149

1.06

0.06

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

341

1.04

0.05

1.5

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

1.07

0.05

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

372

0.97

0.05

1.5

1.2

2.4

2.9

umol/l

0.68

335

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

125

885

1.02

0.05

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

278

1982

1.01

0.05

1.4

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

160

0.95

0.05

2.0

1.9

14.3

18.5

umol/l

1.08

160

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

124

908

0.98

0.04

1.0

1.1

8.5

6.7

nmol/l

0.18

189

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

257

1.04

0.04

1.4

1.3

41.0

49.4

0.37

110

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

236

1.04

0.04

1.4

1.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

258

1.03

0.03

2.2

2.0

32.4

7.4

ug/l

0.36

151

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

517

1.02

0.03

1.4

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.06

0.02

1.9

1.5

—

(3024316) Viscosity of Plasma

1.06

0.02

2.4

2.0

1.5

1.8

mpas

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

858

6197

1.00

0.02

3.2

4.0

107.2

75.8

u/ml

0.98

823

5945

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

366

0.98

0.01

1.3

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

185

0.97

0.01

22.2

9.9

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

125

1.04

0.01

1.3

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.01

0.00

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

120

1.02

0.00

3.8

4.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

130

1.00

0.00

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

648

1.00

0.00

1.2

1.3

6.3

6.1

mmol/l

0.39

607

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

335

0.99

0.00

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

126

0.97

0.00

1.1

1.4

0.1

nmol/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

495

3563

1.00

0.00

1.8

1.6

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

101

1.00

0.00

1.3

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

187

1.00

0.00

1.6

1.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

164

1.01

0.00

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.4

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3033016) Trichoderma viride IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.92

0.00

1.2

2.0

1.9

mg/l

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

18.9

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3022725) Serotonin [Moles/volume] in Serum

0.88

0.00

1.7

1.5

846.2

1139.8

nmol/l

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3034610) Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3029088) Stachybotrys chartarum IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.97

0.00

1.2

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.97

0.00

1.0

0.4

1.2

u/ml

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_HEARTFAIL_ALLCAUSE and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_HEARTFAIL_ALLCAUSE	1.756 [1.63, 1.89]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.02

During the follow-up period (1.1.1998 — 31.12.2019), 92684 out of 147808 females with I9_HEARTFAIL_ALLCAUSE died.

Males

Parameter	HR [95% CI]	p-value
I9_HEARTFAIL_ALLCAUSE	2.309 [2.11, 2.53]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 81095 out of 132836 males with I9_HEARTFAIL_ALLCAUSE died.

Mortality risk

Mortality risk for people of age

years, who have I9_HEARTFAIL_ALLCAUSE.

N-year risk	Females	Males
1	0.119%	0.308%
5	0.676%	1.881%
10	1.772%	5.011%
15	3.342%	9.27%
20	5.681%	15.096%

Relationships between endpoints

↥

Index endpoint: I9_HEARTFAIL_ALLCAUSE – All-cause Heart Failure

GWS hits: 10

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

All-cause Heart Failure

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints